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In Saccharomyces 	cerevisiae 	the enzymatic pathway for 
biosynthesis of aromatic amino acids is branched, culminating in the 
formation of phenylalanine, tyrosine and tryptophan. The last 
biosynthetic reaction common to phenylalanine and tyrosine, the 
formation of prephenate from chorismate, is catalsyed by the enzyme 
chorismate mutase, encoded by the AR07 gene.. 
An aro7 mutant of Sacoharomyces cerevisiae was used to screen a 
wild-type gene bank, based on the vector YEp13, for complementation 
of the aro7 phenotype. One such transformant was isolated; aro7 
complementation being correlated with the presence of the plasmid 
(pJFB1). Yeast strains transformed with pJFB1 displayed increased 
levels of chorismate mutase activity compared to wild-type. 
A restriction map of pJFB1 has been obtained and the cloned 
insert estimated to 5.3 kb. Deletion analysis localised the the 
complementing activity to a region spanning a HiriiIII site at 12.7 
on the map. Transcriptional analysis identified a polyadenylated 
transcript of approximately 1 kb. 
In vitro mutagenesis of pJFB1 resulted in several transformants 
resistant to levels of the phenylalanine analogue -thienylalanine 
inhibitory to the wild-type transformant. Chorismate mutase assays 
indicated that two of the mutants (J14-261V6 & J14-261V9) were 
resistant to the feedback-inhibition by tyrosine displayed by 
wildtype strains. Analysis of the effect of other aromatic amino 
acids on chorismate mutase activity showed that tryptophan 
counteracted this inhibition. 
Viii 
Analysis of the effect of tyrosine in the growth media on enzyme 
activity indicated that the wild-type ATh07 gene was repressed by 
tyrosine, a phenomenon not previously reported. Two of the 
-thienylalanine resistant mutants (J14-261V3 & J14-261V9) appeared 
to be resistant to this repression. 
This was confirmed by transcriptional analysis which showed that 
the level of AI7 transcript decreased with increasing tyrosine 
concentration. In strain J14-261V9 the AR07 transcript level was 
not affected. J14-261V9, therefore, appears to be a double mutant, 
resistant to both feedback-inhibition and repression by tyrosine. 
ix 
1. INTRODUCTION 
The systematic investigation of how amino acids are 
biosynthesised was well under way long before the field of 
biotechnology emerged. From its earliest beginnings, however,the 
commercial production of amino acids has been an important area of 
biotechnology. The first report of the production of an amino acid 
describes the preparation from sea tangles of the flavouring agent 
sodium glutamate (Ikeda, 1908). This work led to the commercial 
production of monosodium glutamate as a seasoning agent from acid 
hydrolysates of wheat gluten or soyabean protein. Today glutamate, 
cysteine, glycine, alanine, lysine, methionine, threonine and 
tryptophan are routinely used throughout the world as flavour 
enhancers and additives in both human and animal feedstuffs. 
The amino acid phenylalanirie was, however, of relatively minor 
importance until the dynamic rise in popularity of the new artificial 
sweetener, Aspartame, caused interest in the commercial production of 
phenylalanine to increase dramatically. Aspartame, an aspartyl 
phenylalanine methyl ester produced by G.D. Searle & Co., now 
dominates the market for low calorie sweeteners, being some two 
hundred times sweeter than sugar. The demand for phenylalanine has, 
therefore, risen accordingly. Several different methods of producing 
phenylalariine have been developed by the main suppliers of the amino 
acid (Klausner, 1985) but their cost still remains the limiting factor 
in the production of Aspartame. 
In an effort to increase production and reduce expenditure, 
research has turned to genetics with the aim of isolating bacterial 
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strains that overproduce phnylalariine. This has already been achieved 
in E. coil (B. Carter, personal communication). In such a highly 
competitive market, however, new ways are being sought to maximise 
production. These must remain financially feasible when applied to 
industrial manufacture. 
Recently interest has been shown in the yeast Saccharoinyces 
cerevisiae as a means of producing phenylalanine. The potential 
advantages of using yeast as opposed to bacterial systems include 
The biosynthetic pathway for amino acid production in yeast is 
fairly well understood and characterised by genetic mutations 
(Jones & Fink, 1982). 
Its eukaryotic life cycle means that cells can grow as stable 
haploids or diploids. This allows the application of many 
classical genetic techniques. In the isolation of phenylalanine 
overproducers, the stable diploid phase offers a distinct 
advantage over haploid bacterial strains by allowing the 
preferential selection of dominant mutations. 
Many of the recombinant DNA techniques commonly used with bacteria 
can now be applied successfully to yeast systems. Combined with 
classical methods, these result in a wide range of procedures 
available for the genetic manipulation of the cell. 
Large scale fermentation technology in yeast is well established 
and there are no toxicity or phage problems associated with its 
use. 
The original aim of this project was, therefore, to genetically 
manipulate the yeast Saccharomyces cerevisiae in a directed manner to 
maximise overproduction and secretion Qf phenylalanine with the long 
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term view that this may result in a very efficient method of producing 
the amino acid at commercially useful levels. 
1.1 ThE AROMATIC AMINO ACID BIOSYNTHETIC PAThWAY. 
The enzymatic pathway for the biosynthesis of phenylalanine in 
yeast is branched, culminating in the formation of the three aromatic 
amino acids; phenylalanine, tyrosine and tryptophan. It is similar but 
not identical to the pathway in E. coli in which it has ben studied in 
more detail. The pathway has been well characterised by the isolation 
of mutant strains which are defective in various key biosynthetic 
steps throughout the system. The complete aromatic amino acid 
biosynthetic pathway for Saccharomyces cerevisiae is illustrated in 
Fig. 1.1 which gives gene designations and enzymes involved. Table 1.1 
lists the enzymes produced by the specific genes. 
Synthesis of phenylalariine, tyrosine and tryptophan proceeds via 
a common route to chorismate, at which point the pathway branches. One 
branch leads to tryptophan, the other to phenylalanine and tyrosine. 
The common pathway begins with the condensation of 
erythrose-4-phosphate, an intermediate of the pentose phosphate 
pathway, and phosphoenolpyruvate, an intermediate in glycolysis, to 
yield deoxy-D-a.rabino-D-heptulosonate-phoSphate (DAHP) (Jones & Fink, 
1982). This reaction is catalysed by either of two isoenzymes of DAHP 
synthase (Lingens et al., 1967) encoded by the AF03 and AF04 genes 
(Meuris et al., 1967). Meuris and his coworkers isolated mutant 
strains bearing deficiencies in both synthases and showed that a 
double mutant strain was auxotrophic for all three aromatic amino 
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Figure 1.1 	Biosynthetic pathway of aromatic 
amino acids in Saccharomyces cerevisiae. 
Genetic blocks are indicated. (Adapted from 
Jones & Fink, 1982) 
erythrose-4 -phosphate + phospho enolpyruvat& 
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TABLE 1.1 Genes and enzymes in the aromatic 
amino acid biosynthetic pathway 
GENE 	 ENZYME 
AR031AR04 	 deoxy-D-heptulosonatephosphate synthase 
AJ1C 	 dehydroquinate synthase 
AR01E 	 dehydroquinate dehydratase 
AR01D 	 shikimate dehydrogenase 
AROJB 	 shikimate kinase 
AR01A 	 3- enolpyruvoyl sh ikimate- 5-P synthase 
AR02 	 chorismate synthase 
.4ROT chorismate mutase 
P1142 prephenate dehydratase 
TYR1 prephenate dehydrogenase 
TRP2177?P3 arithranilate synthase 
TRP4 anthranilate transferase 
TRPJ anthranilate isomerase 
77?P3 indole-3-glycerol-P synthase 
7RP5 tryptophan synthase 
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acids plus p-aminobenzoate and p-hydroxybenzoate. 
The AROJ cluster of Saccharomyces cerevisiae is thought to be a 
single transcription unit encoding one multifunctional polypeptide of 
molecular weight 15,000Da(De Leeuw, 1967). The five sequential 
enzymatic activities convert DAHP to 3-enolpyruvoyl 
shikimate-5-phosphate (Gaertner & Cole, 1977). Genetic and biochemical 
evidence indicates that this organisation is analogous to that found 
in Neurosjxra crassa (Lumsden & Coggins, 1969) and probably other 
fungi (Ahmed & Giles, 1969). In contrast to this, the bacterial 
arrangment is one of scattered genes and separate products (Pittard & 
Wallace, 1966). The next step is the generation of chorismate. This 
is catalysed by chorismate synthase, the product of the AR02 gene (de 
Leeuw, 1967). 
From chorismate, the last common precursor, the pathway branches. 
One branch leading to tryptophan production, the other to the 
production of phenylalanine and tyrosine. 
The products of the TRP2 and TRP3 genes form a protein complex, 
anthranilate synthase, even though they are transcribed from two 
separate genes (Doy & Cooper, 1966). Together they catalyse the 
formation of anthranilate from chorismate, the first step in the 
tryptophan branch. 
The 77?P3 gene product is also active irrespective of its 
aggregation with anthranilate synthase. After the two enzymatic steps 
catalysed by 7RP4 and TRP1, the 77P3 protein functions again to 
catalyse the formation of indole-3--glycerol-phosphate. Accordingly 
there exists mutants in TRP3 influencing either the 
indole-3-glycerol-phosphate synthase activity, or the anthranilate 
synthase activity or both activities together (Schurch, 1982). 
Although apparently a single polypeptide, tryptophan synthase 
catalyses a two step reaction resulting in the production of 
tryptophan (Zalkin & Yanofsky, 1982). 
The branch in the pathway leading to phenylalanine and tyrosine 
proceeds by rearrangment of chorismate to yield prephenate. The enzyme 
responsible for this step is chorismate mutase, specified by the AJ?07 
gene (Kradolfer et al., 1977). Mutants in the gene are auxotrophic 
for both phenylalanine and tyrosine. 
Again the pathway branches. The route leading to the synthesis 
of tyrosine begins with the conversion of prephenate to 
4-hydroxyphenyl pyruvate, the immediate precursor of tyrosine, by the 
enzyme prephenate dehydrogenase, the TYRJ gene product (Lingens et 
al., 1966). 
Alternatively, prephenate dehydratase, encoded by the P1i42 gene 
(Lingens et al., 1966), catalyses the formation of phenylpyruvate 
which is transaxninated to phenylalanine. There is genetic and 
biochemical evidence for the existence, in yeast, of multiple 
transaininase activities which carry out this final step (Jones & Fink, 
1982). 
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1.2 REGULATION OF THE PAThWAY. 
The regulation of metabolic pathways in eukaryotic cells is 
still poorly understood compared with that of prokaryotes. A problem 
in studying the regulation of a biosynthetic pathway in yeast is that 
the structural genes are generally scattered over the genome and each 
may be seperately regulated by a different set of signals, as well as 
by different receptors for the same signals. In bacteria, the genes 
for a given pathway are often linked in an operon, and all respond to 
the same metabolic signals mediated through the same receptors 
(operators and promoters). For this reason the analysis of one gene's 
regulation in E. coil may provide sufficient information on the 
regulation of an entire pathway. In Saccharomyces cerevisiae no 
operons exist and no polycistronic mRNA seems to be synthesised 
(Peterson & McLaughlin, 1973). This makes a study of regulation of a 
pathway much more difficult since each gene may be regulated 
differently. 
In yeast and bacteria the biosynthesis of amino acids is 
regulated by both feedback inhibition and repression. Both methods 
respond to the amino acid levels in the cell. In feedback inhibition 
the amino acid interacts with its target enzyme allosterically so that 
the enzyme loses its affinity for its biosynthetic substrate. The loss 
of activity is therefore immediate. The most common situation is that 
the first enzyme of a pathway is inhibited by the end product of the 
pathway as a whole. In repression the endproduct of the biosynthetic 
pathway inhibits transcription of certain enzymes thereby reducing 
their levels of expression. 
In yeast, feedback inhibition is reported to be the principle 
regulatory control in the formation of the aromatic amino acids. 
Although the aromatic pathways are subject to general amino acid 
control there is no evidence for specific transcriptional regulation 
(Deneu & Demain, 1981). Repression is a less important control since 
the amplitude of the effect is low. Unlike bacteria in which 
repression can cause more than a hundredfold decrease in enzyme 
levels, repression in yeast may be only a twofold effect (Miozarri et. 
al., 1978). 
The feedback inhibition of both DAHP synthase enzymes provides 
the prime control and limits entry into the system (see Fig. 1.2). Both 
the A3303 and the ATh04 genes code for DAN? synthase but the product of 
the former is inhibited by phenylalanine (Meuris, 1967) and uncharged 
tRNA-phe (Meuris, 1973) while the latter product is inhibited by 
tyrosine (Lingens et aJ., 1966) and by tyrosyl-tRNA (Meuris, 1973). 
Mutants defective in either gene are prototrophs because of the 
compensating isoenzyrne. However, aro3 mutants are unable to grow in 
the presence of tyrosine since it inhibits the functional AR04 gene. 
Reciprocally aro4 mutants are phenylalanine sensitive. So far as is 
known, tryptophan plays no part in this regulation but rather exerts 
control in an indirect fashion (see later). The subsequent AF01 and 
ATh02 encoded steps of the common pathway seem to be insensitive to 
allosteric effects. 
At chorismate the pathway branches. In the normal yeast cell 
tryptophari is preferentially synthesised (Lirigens et a1., 1967), due 
to the kinetic parameters of the pathway-specific enzymes in their 
reactions with the common chorismate intermediate. Anthranilate 
synthase (TRP2, TRP3) shows normal Michaelis-Menten kinetics, that is, 
/ 

















Figure 1.2 	Regulation of the aromatic amino 
acid pathway. (Adapted from Jones & Fink, 1982). 
Feedback inhibition, -. - - Counteracts 
feedback inhibition, - - -overcomes feedback 
inhibition and activates. 
it can act on the substrate at low concentrations. Chorismate mutase 
(AJ7) displays sigmoidal kinetics and, consequently, is active only 
when chorismate concentrations increase. Anthranilate synthase, 
therefore, has a higher affinity than chorismate mutase for 
chorismate, but once the cell's requirment for tryptophan is 
satisfied, excess tryptophan feedback inhibits the TRP2 product 
resulting in increased concentrations of chorisruate for chorismate 
mutase activity. In addition this activity may be enhanced by 
tryptophan-induced conformational changes (Kradolfer et al., 1977). 
As well as being tryptophan activated, chorismate mutase is inhibited 
by tyrosine (Lingens et al.,1966) so that the balance between these 
end products controls the direction of chorismate metabolism. 
Phenylalanine does not seem to have any regulatory role up to this 
point (Lingens et al., 1966). 
Prephenate, the product of the chorismate mutase reaction, is the 
branchpoint between phenylalanine and tyrosine. Once again the kinetic 
properties of the enzymes determine the preferential synthesis of 
phenylalanine over tyrosine. Prephenate dehydratase (PHA2) displays 
normal Michaelis-Menten kinetics whereas prephenate dehyrogenase shows 
positive co-operativity (Lingens et al.,1967). Production of 
phenylalanine is determined by the end product inhibition of 
prephenate dehydratase while tyrosine synthesis is controlled by the 
allosteric inhibition, by tyrosine, of prephenate dehydrogenase. 
Phenylalanine eliminates this inhibition and normalises the sigmoidal 
kinetics of prephenate dehydrogenase in the absence of tyrosine 
(Lingens et a1.,1967). Thus when phenylalanine is in excess 
prephenate is channelled into the tyrosine arm, due to the fact that 
the dehydratase is inhibited. The activity of the dehyrogenase is 
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enhanced in a mariner analogous to the tryptophan effect on chorismate 
mutase. When phenylalanine is limiting, however, prephenate will pass 
into the phenylalanine arm, whether tyrosine is present or not, 
because of the low affinity of the dehydrogenase for prephenate when 
phenylalanine is absent. As a consequence of these reactions the 
aromatic amino acid pools normally fill in the order : tryptophan, 
phenylalanine, tyrosine (Jones & Fink, 1982). 
Knowledge of the regulatory mechanisms controlling the level of 
transcription in yeast is not extensive and the more complex 
arrangement of the genetic material makes extrapolation of data 
obtained from prokaryotes difficult. 
Preliminary work by Lingens et a1.(1967) found that transcription 
of the ATh03 and AF?04 genes is not affected by any of the aromatic 
amino acids, either singly or in combination. Chorismate mutase seems 
to be induced by tryptophan and prephenate dehydrogenase by 
phenylalanine, while prephenate dehydratase is repressed by 
phenylalanine. The significance of these effects in vivo is still 
unclear. 
More information, however, is available on the control of the 
tryptophan pathway. Doy & Cooper (1966) reported that anthranilate 
synthase production is repressed by tryptophan. In contrast, Fantes et 
al. (1976) found no repression of the enzymes of the pathway by 
tryptophan. In an effort to resolve these contradictory reports, 
Miozzari and his co-workers (1978) showed that the activity of all the 
tryptophan enzymes is proportional to their gene dosage, indicating 
that they are transcribed and translated constitutively. An increase 
in enzyme levels was elicited by growth under tryptophan limiting 
12 
conditions but it was shown that this derepression is not a specific 
response of the cell to tryptophan limitation, since derepression of 
the enzymes also occurred upon limitation of unrelated amino acids 
such as leucine, histidine and arginine. 
1.3 GENERAL aJN'flDL OF AMINO ACID BICSYNTHEIS 
Co-regulation of enzymes of different amino acid biosynthetic 
pathways in fungi, called metabolic interlock, was first described in 
Neurospora crassa (Carsiotes & Jones, 1974). A similar regulatory 
system was described in Saccharomyces cerevisiae by Schurch et al. 
(1974) and has been termed "the general control of amino acid 
biosynthesis" by Delforge et al. (1975). 
In yeast, a number of enzymes in different amino acid 
biosynthetic pathways are under this common control and derepress when 
any single amino acid becomes limiting. For example, starvation for 
histidine leads not only to elevated levels of histidine biosynthetic 
enzymes but also causes elevated levels of the tryptophan, arginine, 
lysine and isoleucine-valine pathways (Jones & Fink, 1982). This 
cross-pathway regulation is known to affect at least twenty-four 
different enzymes in the basic, the aromatic and other branched chain 
amino acid pathways (Jones & Fink, 1982). 
Regulation appears to occur at the level of transcription because 
increased levels of several of the enzymes subject to the general 
control have been correlated with corresponding increases in mRNA 
levels (Messenguy & Dubois, 1983), and has been shown to be elicited 
by the under-charging of single tRNA molecules (Messenguy & 
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Delforge, 1976). 
Five trans-acting regulatory genes that act as positive effectors 
for derepression have been identified; GCNI-5 (Schurch et ad., 1974; 
Wolfner et ad., 1975; Penn et ad., 1983). The wildtype products of 
GCN1, 3 and 4 are necessary for initiation of biosynthetic gene mRNA 
derepression, whereas GC7'J2, itself under general control, is required 
for maintenance of elevated mRNA levels (Penn et al., 1984). GCN2 has 
been shown to be transcriptionally regulated, whereas GCN4 is 
translationally regulated (Hinnebusch, 1984). There are also 
trans-acting control genes which are negative regulators, acting to 
limit the expression of genes under general control. Three such 
genes, GCD1, 2 and 3 have been identified (Wolfner et ad., 1975; 
Myers et ad. , 1986). 
Analysis of the interactions between different mutations by 
several research groups (Wolfner, et ad., 1975, Niederberger et ad., 
1981, Hinnebusch & Fink, 1983; Myers et ad., 1986) has shown that, in 
the cases studied, constitutive mutations are epistatic to the 
mutations causing non-derepressible synthesis. This has allowed the 
construction of a model concerning the roles of the different 
regulatory molecules in general amino acid control (see Fig. 1.3). 
The coincident control of a large number of genes involved in 
amino acid biosynthesis suggests a signal common to all of the genes. 
Cis-acting regulatory mutations have been identified in the 5' 
non-coding regions of the HIS3(Struhl, 1982) and HIS4 (Donahue et ad., 
1983) genes which prevent normal derepression of these genes. 
Comparative analysis of the upstream regions has defined a recognition 
site for a positive regulatory factor that mediates general amino acid 
14 
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Figure 1.3 	Model of general amino acid 
control. (Adapted from Myers et a]., 1986). 
- negative control, + positive control. 
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control. This site has a consensus sequence 5'TGACC 3' and has been 
found in multiple copies upstream from sixteen different genes, all 
subject to general control (Hill et al., 1986). The QCN4 protein 
binds to this sequence, activating transcription (Hope & Struhi, 
1985). 
Studies with mutant strains defective in general control showed 
clearly that all the tryptophan biosynthetic genes except 7P1 are 
subject to general control (Miozzari et al., 1978), although in a 
non-coordinated manner (Niederberger et al., 1981); each enzyme being 
derepressed to a different extent under various limiting conditions. 
This situation is similar for several pathways including enzymes in 
the isoleucine-valine pathway (Magee & Hereford, 1969). This 
demonstrates that under the influence of external amino acid imbalance 
the general control may derepress specifically appropriate target 
enzymes rather than all enzymes potentially under its control 
(Niederberger et al., 1981). Possibly this is because, under the more 
physiological conditions of external aminoacid imbalance, the 
threshholds for derepression of most enzymes under the general control 
are not reached. 
Recent work with Saccharomyces cerevisiae AR03 and AR04 genes 
(Teshiba et al., 1986) has shown that both the DAHP synthase 
isoenzymes also respond equally well to the general control. This 
explains earlier results (Niederberger, 1981) which showed that 
addition of tyrosine and phenylalanine led to severe growth inhibition 
in ndr (gcn) mutant strains, in which there is no derepression, but 
not in the wild-type strain. Since normal growth was restored by 
tryptophari it suggests that growth inhibition was caused by tryptophan 
limitation due to feedback inhibition of the DAHP synthases by 
16 
phenylalanine and tyrosine. This does not happen in the wild-type 
presumably because tryptophan limitation will trigger the general 
control and the resulting derepression of the AR03 and AR04 genes 
will counteract the feedback inhibition allowing tryptophan to be 
synthesised. 
Tyrosine alone also inhibits growth in ndr strains possibly due 
to phenylalanine limitation. This suggests that chorismate mutase is 
also under general control although it has not been tested directly. 
To date, there is no direct evidence showing that any of the other 
aromatic amino acid biosynthetic enzymes are under general control. 
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There are essentially three ways that over production of 
phenylalanine can be achieved in yeast: 
The isolation of mutants resistant to phenylalanine 
analogues. 
Isolation of regulatory mutants in defined genes in the 
pathway. 
Using recombinant techniques, wild-type alleles or feedback 
resistant alleles of key genes in the pathway may be cloned. 
1.4.1 Analogue Resistant Mutants 
Traditionally, overproducers of amino acids have been isolated 
by selecting for resistance to amino acid analogues even when there 
has been no prior knowledge of the regulation of the biosynthetic 
pathway. On the assumption that certain phenylalanine analogues 
inhibit growth by being incorporated into the protein instead of 
phenylalanine and that the extent of this incorporation is dependent 
on the relative intracellular levels of phenylalanine and the 
analogue, it would be expected that one class of analogue-resistant 
mutants would include ones with a greatly increased rate of 
phenylalanine synthesis. Overproducing strains of E. coil, B. 
subtiiis and some Corynebacteria have been successfully isolated from 
mutants resistant to phenylalanine analogues (B. Carter, personal 
'U 
communication). It seems reasonable, therefore, that such an approach 
should be feasible in yeast. 
The major drawback in this approach, however, is that the genetic 
basis of over-production is unknown. Consequently it would be 
difficult to integrate this kind of programme with the more reasoned 
approaches of classical genetics or genetic engineering. 
A programme of this nature would require the isolation and 
investigation of large numbers of mutants resistant to one or other of 
multiple analogues, so it is important that a simple screening 
procedure should be designed (see section 2.11). 
There is a possibility that some of the resistant colonies might 
be analogue-uptake mutants instead of overproducers. These could be 
weeded out by replica-plating onto a range of different phenylalanine 
analogues. Overproducers should be cross-resistant whereas the 
majority of uptake mutants should not. 
An alternative approach would be to mutagenise and screen diploid 
cells. Uptake mutants are by their nature recessive and consequently 
in a diploid cell both copies of the appropriate gene would require 
the introduction of a mutation. If the frequency of a mutation in one 
gene copy is 10 -6 survivor- ' then a mutation in both copies will occur 
in 10-12 survivor- ' i.e. very rarely. It is likely that phenylalanine 
overproduction will result from regulatory mutants particularly 
feedback-resistant mutations. These by their nature may be dominant 
and therefore only one copy of the gene would need to be mutagenized 
to obtain a phenylalariine overproducer and thus an analogue-resistant 
mutant. It therefore seems reasonable to expect that mutagenesis of a 
diploid strain would preferentially result in the selection of 
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analogue-resistant mutants due to phenylalanine overproduction. 
The above is a good example of the way one can use the life-cycle 
of yeast to advantage. Under appropriate conditions diploids will 
undergo meiosis and sporulation, resulting in the production of four 
haploid spores. If analogue-resistance is due to a single nuclear 
gene, two of the haploid spores will give rise to resistant colonies 
and two will give rise to sensitive colonies according to Mendelian 
segregation. It would, therefore, be easy to recover the mutant 
allele in haploid cells. 
The ease of genetic analysis in yeast along with the fact that 
the genetic regulation of the phenylalanine biosynthetic pathway is 
well understood, should permit the more reasoned approach to 
phenylalanine overproduction through the isolation of particular gene 
mutations. 
1.4.2 Regulatory Mutants 
Flux through the phenylalanine pathway is achieved mainly 
through feedback inhibition and activation of key enzymes in the 
pathway. Thus by introducing primarily dominant mutations in the 
genes coding for these enzymes, it should be possible to manipulate 
yeast in a directed manner and so control the flow through to the 
phenylalanine branch, bypassing the controls that exist in wild-type 
cells. 
The first point of regulation in Saccharom.vces cerevisiae is the 
reaction catalysed by DAlI? synthase. Separate, unlinked, genes code 
for this, AF?03 and A104, their products being feedback inhibited by 
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NOTE - The following two pages are out of sequence. 
should be feasible to isolate them using the same rationale as aroi 
mutants; as the flow is directed away from tyrosine and towards 
phenylalanine such mutants will have enhanced sensitivity to tyrosine 
analogues. Feedback insensitive mutants of PHA2 should also be 
resistant to analogues of phenylalanine. 
Such mutants have not been isolated in yeast although similar 
work has been carried out using E. coil (Im & Pittard, 1971). In E. 
ccii chorismate is converted through prephenate to phenylpyruvate by 
the multifunctional enzyme chorismate mutase prephenate dehydratase. 
This enzyme is feedback inhibited by phenylalanine. Mutants were 
isolated which grew on concentrations of p.-fluorophenylalanine 
inhibitory to wild-type, and found to excrete phenylalanine. After 
further analysis, however, these mutants turned out to be regulatory 
mutants; being insensitive to repression rather than inhibition by 
phenylalanine. 
It should be possible, using these regulatory mutants, to divert 
the flow through the pathway to phenylalanine overproduction. This 
could be assisted by blocking the flow into the other branches with 
the use of defective alleles in the tryptophan and tyrosine pathways. 
This would involve, however, the further complication of adding 
tyrosine and tryptophan to the medium. It may, therefore, be 
advantageous to use "leaky" mutants. Such bradyotrophic strains would 
permit the synthesis of adequate levels of tryptophan and tyrosine 
without excessive utilization of chorismate and prephenate. 
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phenylalanine and tyrosine respectively. Cells which have a defective 
allele at AF?04 will require AR03 encoded enzyme activity to provide 
the flux through the pathway to the three aromatic amino acids. The 
presence of high levels of phenylalanine in the medium will inhibit 
the activity of this enzyme and so cells will not grow in the absence 
of tyrosine. The required mutation is one that will make the AR03 
enzyme resistant to inhibition by phenylalanine. Auxotrophic strains 
were isolated by Meuris et al. (1967) and feedback-insensitive strains 
obtained by selecting for growth of aro4 strains in the presence of 
excess phenylalanine and absence of tyrosine (Meuris, 1973). Similar 
insensitive ar'o4 mutants were selected by growth of aro3 auxotrophs in 
an excess tyrosine but not of phenylalanine. 
Chorismate mutase is subject to activation by tryptophan and 
inhibition by tyrosine (Lingens et al., 1966). In order to facilitate 
the flux preferentially through this branch it should be feasible to 
introduce regulatory mutations in the structural gene AR07. The type 
of mutation required is one that enhances the catalytic activity to 
such an extent that even in the presence of tyrosine and the absence 
of tryptophan, the flux is diverted towards the production of 
phenylalanine. This will result in the production of very little 
tryptophan and so such mutants can be selected by looking for enhanced 
tryptophan-analogue sensitivity. Such a protocol was used by Kradolfer 
and his collegues (1977) and analysis of the resulting mutants showed 
them to be insensitive to feedback inhibition by tyrosine. 
The next regulatory point which could be abolished is the 
reaction catalysed by flni42. Desirable mutations are those which make 
prephenate dehydratase resistant to inhibition by phenylalanine. It 
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1.4.3 Recombinant DNA Methods 
The approach outlined in the previous section can be usefully 
allied to a recombinant DNA approach. Since defective alleles of each 
gene have been isolated (Jones & Fink, 1982) it should be possible to 
clone any gene in the pathway by complementation , using a gene bank 
from wild-type cells to transform the appropriate yeast mutant. 
This has already been achieved with AR03 (Teshiba et al., 1986), 
77?P2 and TRP3 (Aebi et al., 1982). The AM01, TRPI and 7RP4 genes have 
also been isolated by functional complementation of E. coil mutants 
(Larimer et al., 1983, Struhi et al., 1979, Walz et al., 1978), an 
alternative method for isolating genes from a wild-type yeast DNA 
While it is possible to isolate a wild-type gene and introduce 
this on a niulticopy plasmid into yeast, the enzyme produced may still 
be susceptible to feedback inhibition and multiple copies may not 
increase the flux of metabolites significantly. What is required is 
the introduction, by transformation, of the feedback-resistant allele. 
This is now quite possible using In vitro mutagenesis. 
Traditional mutagenesis procedures involve chemical treatment of 
a whole cell and a means of isolating a mutant with the desired 
phenotype from a population of randomly mutagenized and wild-type 
cells. This isolation is aided by the ability to predict the growth 
phenotype of the mutant on certain nutrients or in the presence of 
drugs. 
In vitro mutagenesis is extremely powerful in that only the DNA 
base sequence of a single gene need be altered. The mutagenised gene, 
on its plasmid vector, is reintroduced into the organism and mutants 
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of the required phenotype are selected or screened. Methods exist for 
introducing either random mutations throughout the gene, or directed 
to specific regions in the promoter, effector or active sites in the 
coding sequence (Shortle et al., 1981). The mutations can be deletions 
or alterations in a single base (point mutations). Such methods could 
be used to generate feedback-resistant mutations or otherwise alter 
the regulation of specific enzymes. 
Although the original aim of the project was to engineer 
overproduction of phenylalanine during the course of this work several 
new and interesting aspects of the regulation of the AR07 gene were 
discovered. AR07 encodes the enzyme chorismate mutase which catalyses 
the conversion of chorismate to prephenate (Fig. 1.4) and is known to 
be inhibited by tyrosine (Lingens et al., 1966). Very little, however, 
is known about the regulation of expression of th AF?07 gene in 
Saccharomyces cerevi siae. 
In E. coli there are two enzymes with chorismate mutase 
activity; one, involved in the biosynthesis of tyrosine, also 
incorporates prephenate dehydrogenase activity (T-protein). The other 
is also a bifunctional protein, in the phenylalanine biosynthetic 
pathway, and contains prephenate dehydrat.ase activity (P-protein) 
(Gibson & Pittard, 1968). The gene for the T-protein, tyrA, together 
with the structural gene for tyrosine-sensitive DAHP synthetase, aroF, 
and transaminase A form a single operon, the expression of which is 
controlled by the product of a regulator gene, tyrR (liii et al., 1971). 















Figure 1.4 	Reaction catalysed by the AR07 
encoded enzyme, chorismate mutase. 
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other genes but is controlled by the pheR gene product (Brown & 
Somerville, 1971). The tyrJnd pheR genes are thought to encode 
protein aporepressors which, when combined with either of three 
aromatic amino acids, repress the appropriate biosynthetic genes 
(Brown & Somerville, 1971). In the T-protein, the chorismate mutase 
activity is not inhibited by tyrosine (Christopherson, 1985) while the 
P-protein can only be reduced to 70% activity by phenylalanine (Im & 
Pittard, 1971). 
This project was begun in collaboration with the pharmaceutical 
company G.D. Searle & Co. who commercially produce Aspartame. After a 
year, however, they were taken over by Monsanto and subsequently 
withdrew from the project. The most advantageous consequence of this 
was that the pressure to concentrate research exclusively on 
phenylalanine overproduction was removed. This allowed a more 
thorough investigation of the control of AR137 expression in 
Sacharomyces cerevisiae and its implications for the regulation of 
aromatic amino acid biosynthesis. 
26 
2. MATERIALS AND METHODS 
2.1 STHAINS, PLASMIDS AND DNA 
2. 1. 1 Yeast Strains 
The strains of Saccharoniyces cerevisiae used are listed below 
Table 2.1: Saccharomyces cerevisiae strains used in this work 
STRAIN GENUflTE SOURCE 
312 M4Tc_ aciel 	trpl hi-s4 I.W.Dawes 
313 MAT.,,ade5 
315 MATh 	adel 	trpl 	his4 	leu2 
322 M4Ta 	cdc28-15 	tyrl 	lys2 	cyhi 
DC5 M4Ta Jeu2-3 leu2-13 his3 cani 
SF747-19D MATa leu2-3 Jeull-2 his4 ura3-52 
ga12 MEL4 sucO 
A236-57B MATa leu2-3 aro7 trpl met4 
lysli his8 suc2 M4,L3 B.L.A.Carter 
J14-26 MATh leu2-3 leull-2 aro7 trpl From SF747 
ura3-52 inet4 lysil X A237-57B 
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2.1-2  Bacterial Strains 
The strains of Escherichia coli used are listed below 
Table 2.2: E.coii strains used in this work. 
STRAIN 	 GENOTYPE 
JA226 	recBC ieuB6 trpE5 hsdR- hsdM lacY600 	I. W. Dawes 
HB101 	F- recA13 hsdS20 aral proA2 iacYl gaJX2 
rpsh2O xy15 mt1-1 supE44 
2.1.3 Cloning Vectors 
The cloning vector used in the isolation of the A1307 gene was 
YEp13. This is a yeast episomal plasmid derived by Broach et al., 
(1979) from the endogenous yeast 2 pm plasmid. The plasmid is 10.7 kb 
in size and has three distinct regions as shown in Figure 2.1 
The yeast origin of replication contained in the 2im region. 
Sequences from the bacterial plasmid pBR322 containing the 
Co1E1 origin of replication and also the genes encoding anipicillin and 
tetracycline resistance. Single Raid-il and Sail sites are located 
within the TetR gene providing a direct screening procedure for 
inserted DNA via insertional inactivation of the gene. 
The yeast LFU2 gene which allows selection in ieu2 mutants 
of Saccharoinyces cerevisiae 
YEp13 is a shuttle vector. The presence of both yeast and 
bacterial origins of replication allows autonomous replication in both 
hosts and the leu2 gene and those coding for antibiotic resistance 
provide selectable markers in yeast and E.coli respectively. This 
"shuttle" property is very important, allowing rare recombinant 
molecules to be amplified in E.coli after initial transformation and 
isolation from yeast. 
2.1.4 S. cerevisiae Gene Library 
The library used to screen for the AR07 gene was constucted by 
Nasmyth & Tatchell,(1980) by the partial digestion of total yeast DNA 
with the restriction enzyme Sau3A. The fragments generated were cloned 
into the unique Barn 1-11 site in YEp13, producing a pool of plasmids 
containing sequences representing, theoretically, the complete genome 
of S.cerevisiae. 
2.1.5 Probe for rRNA 
A shuttle vector comprising of a 1 kb ThaI/SstI pYIrG12 fragment, 
containing the 18s rRNA gene (Peteset al., 1978), cloned into pSP65 
(Santiago et al., 1986) was obtained from A.J.P. Brown, Dept of 





Figure 2.1 	Restriction map of YEp13. 
pBR322 
Leu2 
RI - EccRI 	B - BanI-1I 
S - Sail 	P - PstI 
X - XhoI 	H - HirxiIII 
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2.2 (M'1'H MEDIA AND CULTIVATION 
2.2.1 Cultivation of Saxtharo,nyces cerevisiae 
The various growth media used are listed below. AmounLq given 
are per litre 
MINIMAL : 20 g D-glucose, 1.7 g yeast nitrogen base (w/o amino acids & 
(NH4 )2 SO4 ), 	5 g ammonium sulphate, 15 g agar (for solid 
media), amino id supplements added where necessary at 50 mg each. 
COMPLETE (YEPD) 	20 g D-glucose, 20 g peptone, 10 g yeast extract, 
15 g agar (for solid media). 
REGENERATION AGAR : 20 g D-glucose, 182 g D-sorbitol, 1.7 g yeast 
nitrogen base, 5 g ammonium sulphate, 20 g agar. 
SPORULATION MEDIUM : 0.5 g D-glucose, 2.2 g yeast extract, 20 g 
potassium acetate, 20 g agar. 
Unless otherwise stated, all strains were grown at 30'C with 
vigourous shaking of liquid cultures. 
2.2.2 Cultivation of E.coli 
The various growth media used are listed below 
LURIA BERTANI (LB) MEDIUM Per litre, 10 g tryptone, 10 g sodium 
chloride, 5 g yeast extract, 15 g agar (for solid media). 
For selection of antibiotic resistance the appropriate 
antibiotic was added to the above media at the following 
concentrations aznpicillin 50 ,ugml - ' ; chlorainphenicol 50 ,igml- 1; 
kanaznycin 30 ,pgml- '. 
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2.3 GENETIC ANALYSIS OF Saccharcrnyces cerevisiae 
Standard techniques were used for the mating, sporulation and 
tetrad dissection of yeast strains (Sherman & Lawrence, 1974; Mortimer 
& Hawthorne, 1975). Tetrad dissection was carried out using a Leitz 
micromanipulator (Sherman, 1975) and resulting recombinant phenotypes 
analysed by replica plating onto drop-out media - minimal media 
supplemented with all the amino acids except the one selecting for the 
auxotrophic marker. 
2.4 TRANSFOR1MATION OF SaotharcRyces cerevisiae 
Yeast strains were transformed by the method of Beggs (1978). 
2.5 TRANSFORMATION OF E. coil 
E. coil strains were made competent according to the method of 
Messing (1983), and stored at -70 ' C. They were transformed as 
described by Dagert & Ehrlich (1979). 
2.6 DNA ISOLATION AND PURIFICATION 
Total DNA from yeast was prepared by the method of Winston et 
al. (1983) 
Plasmid DNA was isolated according to the method of Nasmyth & 
Reed (1980). 
Small-scale preparations of plasmid DNA from E. coil were 
obtained using the alkaline-SDS method of Birnboim & Doly, (1975). 
Large-scale preparations were obtained in the same manner followed by 
centrifugation in CsCl-ethidium bromide gradients (Maniatis et al., 
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1982L 
DNA concentations were estimated from the absorbance of the 
solution at 256 rim. Calculations were based on an OD2515= I being 
equivalent to 50 pgml 1 . 
2.7.1 Restriction Digests of DNA 
Restriction enzymes were used as recommended by the supplier 
(Boehringer, N.B.L.) 
2.7.2 Ligation of DNA 
Ligation was carried out using T4 DNA ligase following the 
protocol of Maniatis et al. (1982). 
2.7.3 Agarose Gel Electrophoresis 
DNA fragments were separated by horizontal, gel electrophoresis 
using a Tris/borate buffer system as detailed in Maniatis et al. 
(1983). Generally 0.7% (w/v) agarose gels were used, however 1% and 
1.5% gels were used to give improved resolution of smaller (less than 
2 kb) fragments. Gels contained 0.5 pginl 1 ethidium bromide allowing 
DNA to be visualised under UV illumination and fragment sizes were 
calculated by comparison with standards of HithIII digested lambda 
DNA. 
2.7.4 Electro-elution of DNA 
Digested fragments of DNA were recovered from agarose gels by 
electroelution onto dialysis membrane (Smith, 1980), and subsequently 
purified and concentrated by running through an Elutip-d column 
according to manufacturers instructions (Schleicher & Schuell). 
2.7.5 Radio-active Labelling of DNA 
Plasmids and fragments of DNA were labelled with (O 32 P) dXrP 
(Ainersham) by nick-translation using the BRL kit ingredients and 
protocol. Incorporation of the radio-active isotope was estimated by 
measuring Cerenkov radiation using a Packard 3330 scintillation 
spectrometer. Measurments were made on a sample of DNA fixed to a 
glass microfibre filter (Whatman), before and after 2 X 5% (w/v) TCA 
washes; the ratio giving approximate percentage incorporation. 
2.8 METHODS FOR ANALYSIS OF RNA 
2.8.1 Isolation of RNA From Sarxharciyces cerevisiae 
Total yeast cellular RNA was prepared following the method of 
Weir-Thompson & Dawes, (1984). 
PolyA4 -RNA was isolated by passing total RNA samples through an 
oligo-dT cellulose column equilibrated with binding buffer (0.4 M 
NaCl, 10 mM Tris/HC1, 1 mM EDTA, 0.2% SDS, pH 7.4). The bound 
polyA-RNA was eluted by washing the column with elution buffer (10 MM 
Tris/HC1, 1 mM EDTA, 0.2% SDS, pH 7.4), the RNA species were identified 
by their absorbance at 260 nm. 
2.8.2 Gel Electrophoresis of RNA 
RNA fractions were denatured then separated by electophoresis 
through 1% agarose gels containing 2.2 M formaldehyde as described by 
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Maniatis et al. (1982). 
2.8.3 Northern Hybridisation 
Following electrophoresis, the RNA gel was treated with alkali 
and then neutralised according to Maniatis et al. (1983). The RNA 
fractions were transferred to nitrocellulose and hybridised with 
labelled DNA probes following the protocol of Thomas (1980) except 
that dextran sulphate was omitted from the hybridisation solution. The 
hybridised filters were exposed to Agfa-Gevaert, Curix RP1 X-ray film 
at -70°C. Films were developed using Kodak LX-24 and fixed with Kodak 
FX-40. 
2.8.4 Slot Blots 
15 p1 20xSSC and 10 p1 37% (w/v) formaldehyde were added to 
40 g RNA and made up to a final volume of 50 ml. Samples were 
denatured by incubating them at 60CC for 15 mm. 25 p1 aliquots were 
transferred to nitrocellulose using BRL's 'Hybri-slot" apparatus and 
fixed by baking at 80'C for 3 h under vacuum. Filters were probed with 
labelled DNA using the procedures described above (2.8.3). 
Dens itometry was performed by scanning autorathographs using Loebi 
Chromoscan 3 apparatus. 
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2.9 CHORISMATE MIflASE ASSAY 
2.9.1 Preparation of Crude Enzyme Extracts 
Strains were grown to late log phase in minimal media with 
appropriate supplements, washed and resuspended in 2 ml enzyme buffer 
per grain wet weight of cells (125 mM Tris-HC1, 2.5 mM EDTA, 60 mM 
)3-mercaptoethanol). 3.3 ml were added to Braun breakage tubes and 
filled to within 1cm from the top with glass beads. Cells were broken 
by shaking for 35 sec in a Braun homogeniser. The extracts were 
decanted and spun through a stainless steel grid to remove the glass 
beads. Extracts were spun at 12 000 rev min - for 10 min and the 
soluble protein, to be assayed, was separated from the pellet and 
lipid layer. 
2.9.2 Chorismate Mutase Assay 
Crude cellular extracts from Saocharomyces cerevisiae strains 
were assayed for chorismate mutase activity using a method adapted by 
M. Edwards (personal communication.) from the assay procedure 
developed for E. coli (Cotton & Gibson, 1964). 
In E. coli, chorismate mutase activity is associated with the 
bifunctional polypeptide encoded by the pheA gene which also has 
prephenate dehydratase activity (Im & Pittard, 1971). The pheA gene 
product, therefore, catalyses the overall conversion of chorismate to 
phenylpTuvate. Chorismate mutase activity is measured as the 
extract-dependent formation of prephenate and phenylpyruvate in the 
presence of chorismate. At the end of the reaction any prephenate is 
chemically converted to phenylpyruvate by incubation In acid solution. 
The concentration of the phenylpyruvate is then measured 
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spectrophotometriCaflY at 320 nm in alkaline solution. 
The assay mixture comprised of 625 pl  of crude extract, 25 1A1l 
5% (w/v) BSA and 350 ,ul enzyme buffer. Samples were prewarmed at 30DC 
for 5 min and the reaction started by adding 250 il 5 mM potassium 
chorismate (prepared from a solution of the barium salt in 0.01 M 
potassium sulphate). At time 0 a 0.25 ml sample was withdrawn and 
added to 0.25 ml prewarmed 3 M HC1, mixed and incubated for a further 
10 min at 30C. Further samples were removed at 2 and 5 min and 
treated similarly. 0.25 ml of acid treated solution was mixed with 
0.75 ml 1 M sodium hydroxide and the A320 measured immediately. The 
rate of increase in Aa20 was then calculated and corrected for the 
control rate in the absence of added extract. This is necessary due to 
the spontaneous (non-enzymatic) conversion of chorismate to 
prephenate. 
The chorismate mutase activity is calculated using an 
extinction coefficient for phenylpyruvate of 17,500 W'cm' 
Activity (Units mg') 	Ao x 0.343 [o x 6 x j_ 
 x 1 
17.5 	V 	P 
NrP 
where A320 = net increase in absorbance 
V = volume of extract (ml) 
P = protein concentration (mgml' 
2.9.3 Estimation of Protein Concentration 
The protein concentration of each of the samples was measured 
using the method of Lowry et al. (1951). 
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2.10 MTrAGENEIS 
2.10.1 In Vitro Mutagenesis 
Plasmid DNA was mutated by treatment with o_methylhydroXylalrlifle 
according to the method of J. Mandeistain (personal communication). 
O_methylhydroxylalfline induces C-T transitions in DNA. 
63 mg o_methylhydroXYlaIfline . HC1 was treated with 2 M sodium 
hydroxide until pH5, the volume added being noted. DNA was added and 
the final volume adjusted to 1 ml with water. The sample was heated at 
50'C for 2 h then precipitated with 2 ml ethanol and cooled at -20'C 
for a further 2 h. The DNA was pelleted by centrifugation and 
redissolved in a small volume of water. The sample was then 
reprecipitated and finally redissolved in a suitable volume of TE 
buffer (10 mM Tris, 1 mM EDTA). This DNA was then used to transform 
suitable yeast strains, using conditions selective for the desired 
mutant phenotype. 
2.10.2 Mutagen Ring Test 
Various strains of SaccharomyCeS cerevisiae were exposed to 
different 	mutagens 
ethylmethaflesUlPhonate) as follows 
1 pi of mutagen was placed in the centre of a YEPD plate spread 
with the yeast strain to be mutated and the plates incubated at 30 • C 
for 48 h.. This resulted in a lawn of colonies except for an area of no 
growth around the mutagen. Colonies around the perimeter of the no 
growth zone which were not killed but mutagenised were then isolated 
by replica plating onto media selective for the desired mutation. 
After incubation at 30C for a further 48 h, colonies of the required 
phenotype formed a ring of growth on the plate and separate colonies 
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could be easily isolated. 
2.11 MEflIODS FUR ASSESSING 1EJYLALANINE OVER-PRODUCTION  
2.11.1 NINHYDRIN TEST 
On reaction with amino acids, ninhydrin solution produces a 
characteristic blue colour. 5 ml samples of extracellular 
supernatants were boiled for 2 min in a 1% ninhydrin (indanetrione 
hydrate) solution and their absorbance read at 440 run. 
2.11.2 Bioassay of Extra cellular Supernatants 
Wild type yeast cells cannot grow on synthetic complete media 
lacking phenylalanine if it contains 100 pginl - ' .-thienylalanine, an 
analogue of phenylalanine. Filter paper discs (3 mm diameter) 
impregnated with a solution of phenylalanine placed on a lawn of yeast 
spread on such media will allow growth in the surrounding area; the 
diameter of this growth "halo" being related to phenylalanine 
concentration. 
The ability of mutant yeast strains to secrete phenylalanine 
was tested by impregnating the filter paper discs with their 
extracellular supernatantand noting if they supported a "halo" of 
wild-type growth around them. The amount of phenylalanine secreted 
could be roughly estimated by comparison with phenylalanine standards. 
2.11.3 Bioassay Using Phenylalanine Auxotrophs 
Mutant yeast strains overproducing phenylalanine will be 
surrounded by a high local concentration of this amino acid in agar 
medium. This assay is based on the fact that this secreted 
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acetone. The paper was left to dry at room temperature then placed at 
100°C for 20 sec. The resulting amino acid spots could be identified 
by comparison with the known standards. 
2.11.4 Thin Layer Chromatography 
Amino acids secreted by mutant yeast strains were also analysed 
using a thin layer chromatography system. 
10 il (5x2pl) aliquots were spotted on TLC aluminium sheets 
precoated with silica gel F254 (Merck), 3 cm from the base. This was 
placed in a chromatography tank 1 cm deep in the solvent ( butanol: 
acetic acid: water of 4:1:1 by volume) and left until the solvent 
front had reached half-way up the sheet (approx. 2 h). The sheet was 
then dried and sprayed with a solution of 0.2% nirthydrin in acetone. 
On drying the resulting spots could be identified by comparison with 
amino acid standards. Intracellular supernatants obtained by the 
method of Dickinson et al. (1985) were also analysed this way. 
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3. ISOLATION AND ANALYSIS OF ANALOGUE RESISTANT MUTANTS 
3. 1 INT1JDUCTION 
Preliminary work carried out at G.D. Searle & Co. indicated that 
it was possible to isolate Saccharom.vces cerevisiae strains which 
overproduced phenylalanine by mutating yeast cells and selecting for 
resistance to the phenylalanine analogue , -thienylalanine. In this 
feasibility trial, one analogue resistant mutant, out of only eight 
studied, overproduced pheneylalanine to such an extent that it 
secreted 1 g 1- ' into the medium (B. Carter, personal communication). 
The aim of this section was, therefore, to continue with these 
experiments; isolating new analogue-resistant strains, improving their 
phenylalanine output and developing simple assay procedures to detect 
and measure this overproduction. 
3.2 ISOLATION OF MUTANTS 
Mutant strains resistant to the phenylalanine analogue 
frthienylalanine were obtained by exposing Saccharomyces cerevisiae 
strain 312 to Nmethyl_N'_nitro-N-nitrOSogUar1idifle (mutagen ring test 
- see 2.10) and selecting for growth on media containing 200 pg ml- ' 
-thienylalanine. Prior to mutagenesis 312 failed to grow at 
-thienylalanine concentrations above 60 pg ml -1 . Ten mutant colonies 
were isolated. 
Since high levels of phenylalanine are often deleterious to 
yeast cells, strain 312 was previously tested to establish that it 
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could tolerate any excess phenylalanine that the resulting mutants 
may have produced. 
3.3 ASSAY FOR SECRETION OF PHENYLAIANINE 
The mutant strains and wild-type 312 were grown in minimal media 
(plus appropriate supplements) for 36 h, their extracellular 
supernatants treated with a 1% ninhydrin solution (see 2.11.1) and 
their absorbance read at 440 nm (Table 3.1). On reaction with amino 
acids ninhydrin solution produces a charateristic blue colour. This 
experiment, therefore, should give an indication of whether 
phenylalanine was excreted by the -thienylalanine resistant mutants. 
TABLE 3.1 Absorbance at 440 nm of extracellular 









31 2NG2 0.18 312NG8 0.46 
312NG3 0.66 312NG9 0.21 
312NG4 0.20 312NG10 0.35 
312NG5 0.32 
312NG6 o.35 312 0.17 
Although a range of absorbances was observed, three strains 
(312NG1, 312NG3 & 312NG8) produced a much more intense blue colour 
than the others. The unmutated 312 gave a very low absorbance, 
producing no discernable blue colour at all. This was not a direct 
test for phenylalanine but it did show that the mutants may be 
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excreting an amino acid of some sort. 
3.4 IDENTIFICATION OF SECRETED AMINO ACIDS 
High voltage paper electrophoresis (HVPE) was used to separate 
and identify the amino acids present in the extracellular 
supernatants. The resulting chromatograph, when stained, showed that 
although there was a slight amount of phenylalanine present, there 
were several other amino acids being produced in much larger 
quantities (Fig. 3.1), including alanine, valine, proline, glutamate 
and tyrosine. The mutants with the higher absorbance at 440 nm did not 
produce more phenylalariine than the others, indicating that it was 
probably the presence of the other amino acids which was the main 
factor in the intensity of the blue colour produced. 
3.5 GENETIC ANALYSIS 
Strains 312NG1, 3 and 8 were crossed with 315, a strain of the 
opposite mating type. The resulting tetrads were dissected into 
separate groups of four spores and after incubation on YEPD media the 
four haploid colonies were replica-plated onto minimal media 
containing 200 1ig rnl' , -thienyla1anine. The growth patterns produced 
showed that resistance to -thienylalanine segregated in a 2:2 manner 
indicating that resistance was due to a single mutation. 
Single diploid colonies were plated on minimal media containing 
200 ,pg ml-1  -thienylalanine. All the diploid colonies grew indicating 
that the ,B-thienylalanine resistant mutation (The) was dominant over 
the sensitive allele (Ths). 
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Figure 3.1 : Separation, by high voltage paper 
chromatography, of amino acids secreted by 
18-thienylalanine resistant strains. 1 - 
standards, 2 - 312NG1, 3 - 312N06, 4 - 312NG10, 
5,6 & 7 - 312. 
L - lysine, A - alanine, V - valine, Pr - 
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3.6 SENSITIVITY ¶10 (YflIER PHENYLALANINE ANALOGUE 
The above three Thr strains were replica-plated onto media 
containing concentrations of in-f luorophenylalanine (300 ig ml- 1 ) and 
p-fluorophenylalanifle (500 pg ml) which inhibited wild-type growth. 
The mutant strains grew on both types showing they were resistant to 
both analogues. This indicated that -thienylalanine resistance was 
possibly due to intracellular phenylalanine overproduction rather than 
a perinease mutation affecting the uptake of the analogue. Multiple 
resistance, in the latter case, would involve several separate 
mutations occurring independently, the frequency of which would be 
very low. Fluorophenylalaflifle may be taken up by the same permease as 
frthienylalanine but such a mutation is unlikely to be dominant in 
diploid heterozygotes since there would always be a wild-type gene 
present to produce a functional permease. 
3.7 ISOLATION OF Tyrl/Thr DCXJBLE MUATA1fl'S 
The ThT strains appeared to produce more tyrosine than 
phenylalanifle, hence, by blocking the tyrosine pathway the flux might 
be diverted through the phenylalanine branch. This would possibly 
increase phenylalanine production especially when coupled with the 
muation causing the Thr phenotype. 
The previous method of selecting analogue-resist-ant mutants was 
repeated, this time using the Tyrl strain 322 which is deficient in 
the enzyme prephenate dehydrogenase. 30 colonies resistant to 
200 pg ml- ' p-thienla1anine were obtained and tested to confirm they 
had retained their tyrosine auxotrophic phenotype. 
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3.8 AMINO ACID ANALYSIS OF DOUBLEM!L]TANTS  
The extracellular supernantants from liquid cultures of the 
double mutants were arialysised using HVPE as before. Most of the 
mutants showed the same pattern of amino acids present as before but 
11 of the 30 showed a slight increase in phenylalanine as well as a 
decrease in the amount of tyrosine produced. 
3.9 TIME COURSE OF pBENYLALANDqE SECRETION 
A 500 ml culture of the double mutant strain 322NG11 was 
incubated at 30 0C, samples being removed at regular time intervals up 
to 140 h. The sample supernatants were analysed by HyPE. 
The resulting chromatograph (Fig. 3.2) showed that phenylalanine 
did not appear until 27-31 h (i.e. late log phase) then steadily 
increased up to 56 h. By 80 h the amount had decreased substantially, 
very little being present at 140 h. Tyrosine was present at high 
levels initially but decreased with time. This was expected since 
tyrosine is added to the media and will be gradually consumed. The 
other amino acids did not appear until approximately 31 h except 
alanine which was present from the start. Repeating this experiment 
with the other ten double mutants produced the same results. 
3.10 EFFECT OF TYROSINE ON PHENYLALANINE SECRETION 
The fact that phenylalanine was not excreted until late log phase 
may be a function of cell growth itself or it may be due to the 
decrease in external tyrosine initially inhibiting the pathway. 
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Figure 3.2 	: FIVPC showing time 
course of phenylalanine secretion 
from strain 322NG11. 
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concentrations (0 to 40 pg ml -1 ) and samples were taken at various 
time intervals, the supernatants were then subjected to HVPE. 
The initial concentration of tyrosine did not seem to affect the 
production of phenylalanine. At all concentrations of tyrosine, 
phenylalanine was present by 38 h. If tyrosine was inhibiting the 
pathway, then phenylalanine would have been expected to appear earlier 
at the lower tyrosine concentrations but this was not so. Tyrosine 
concentration did not seem to affect the appearance of the other amino 
acids either. 
3.11 IM)VF1ENT OF PIIENYLALANINE PRODUCTION  
With the aim of increasing the amount of phenylalanine produced, 
strain 322NG11 was subjected to a second round of mutagenesis. 
Cultures were exposed to EMS (see 2.10) then aliquots plated on Phe 
media which had been previously spread with a phenylalanine 
auxotrophic tester strain A236-57B. The plates were incubated at 30 °C 
for 48 h. 
Mutant colonies could be identified by a "halo" of tester strain 
growth around them due to cross-feeding (see 2.11). Although there 
seemed to be an overall background growth, 12 colonies had a much more 
concentrated area of growth around them. This was much more evident 
when viewed with a binocular microscope (x5 magnification). The 12 
colonies were picked and streaked out on phe media to separate them 
from cross-feeding contaminants. 
(• 
Master plates were made by spotting single colonies of the 
"overproducing" strains (OP) onto YEPD media at regular intervals 
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around the circumference of the plate. Controls of 322NG11 and DC5 
were also on each plate. These were allowed to grow then 
replica-plated onto phe plates containing different concentrations of 
frthienylalanine and spread with the phenylalanine auxotrophic tester 
strain A236-57B. The amount of tester growth around each colony was 
taken as a measure of the phenylalanine excreted. 
The strains which secreted the most phenylalanine were OP1, 2a, 
2c, 5 and 6 (Fig. 3.3). These five strains were able to support the 
growth of the tester strain up to p-thienylalanine concentrations 
of 100 pg ml'. Strains OP2c and 0P9 failed to cross-feed the 
phenylalanine auxotrophic strain above 50 ,pg ml -1 . No "halos" were 
observed around strain 322NG1 1 at 50 pg ml -1 B-thienylalanine. Since 
these mutants were derived from strain 322NG11, it appears that this 
second round of mutagenesis has, in the strains mentioned, improved 
the yield of phenylalariine. 
It is interesting to note that some mutants were resistant to 
250 pg ml- ' p-thienlalanine (322NG11, 0P7) even though they failed to 
support the growth of the tester strain at 100 ug ml -1 , while other 
strains (OP20 had large "halos" around them but did not grow above 
100,ug ml - ' , -thienylalanine. This may be due to the strains 
supporting the tester strain being able to secrete phenylalanine more 
readily than the other strains. 
3.13 QLJANTITATTVE ANALYSIS OF PHENYLAIANINE I )IXEflON 
The extracellu]ar supernatants of the OP strains were analysed by 
thin layer chromatography (TIC) with the aim of quantifying the amount 






Figure 3.3 	Cross-feeding of phenylalanine auxotrophic 
strain, A236-57B, by OP strains. Top row, in clockwise 
direction; OP1, 2a, 2b, 2c, 3, 4 and 322NG11 (centre). 
Bottom row; 0P5, 14, 9, 8, 7, 6 and DC5 (centre). A-O 
B-thienylalanine, 	B-50 1ug m1 1, 	C-100 jig M-1 -1 	and 
D-250 P9  m11. 
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were also run, to act as standards against which the samples could be 
measured. 
Strain 0P5 appeared to produce the most extracellular 
phenylalanine, the concentration was estimated as 0.25 mg m1' (Table 
3.2). This strain plus OP1, 2a, 2c, 6 and 9 all produced more 
phenyalanine than the original strain 322NG11 showing that the second 
round of mutagenesis had improved phenylalanine output. All the mutant 
strains produced much more phenylalanine than the unmutated strain 
322. 
The results of 3.12 indicated that there may be differences in 
the amount of phenylalanine produced by the cell compared to the 
amount that is secreted. The above experiment was, therefore, 
repeated this time analysing the intracellular levels of 
phenylalanine. No significant difference was observed in the amount 
of phenylalanine measured for each strain. This indicated that most of 
the available phenylalanine was secreted by the cells. 
3.14 DISCUSSION 
In summary, several mutant strains of Saccharornyces cerev.isiae 
have been created which show a significantly increased level of 
phenylalanine production compared to wild-type yeast strains. Although 
the phenylalanine levels obtained (approx. 0.25 mg ml -1 ) were not as 
high as those previously achieved by researchers at G.D. Searle 
(1mg m1 1), these results werevery encouraging and indicate that an 
attempt to produce large quantities of phenylalanine using yeast may 
be rewarding. 
The bioassay proved an efficient method for the detection of 
colonies overproducing and secreting phenylalanine and analysis of the 
supernatant by TLC allowed the amount of phenylalanine produced to be 
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Table 3.2 : Concentration of phenylalanine 
(mg ml-1 ) secreted by 	Thr / 7vr1second round 
mutants. 
STRAIN PHENYLALANINE 	STRAIN 	11ENYLALANINE 
OJNC. (mg ml-1 ) CONC. 	(mg nil- ') 
322NG11 0.1 0P5 0.25 
OP1 0.2 0P6 0.2 
OP2a 0.2 0P7 <0.1 
OP2b 0.1 0P8 <0.1 
OP2c 0.2 0P9 0.1 
0P3 <0.1 0P14 0.1 
0P4 <0.1 322 undetectable 
quantified. Further measurments using an amino acid analyser 
would, however, give a more accurate profile of the amino acids 
produced and their relative concentrations. 
The phenotype of the mutant strains indicate that the 
overproduction of phenylalanine is probably caused by a mutation in 
one of the control genes (AR93, ATh04, AI&7, P1i42 or 7YR1) rendering 
its protein insensitive to feedback-inhibition by phenylalanine. 
Further analysis involving the appropriate enzyme assays should 
confirm this and indicate which gene has been mutated. 
The tyrl/Thr double mutant strains appeared to produce more 
phenylalanine than the original Thr strains, therefore, it may be 
possible to improve phenylalanine production further by crossing in 
mutations in other relevant pathways. By introducing the trp2 or trp3 
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mutations, for example, the tryptophan biosynthetic pathway would be 
blocked, possibly directing the flux towards phenylalanine production. 
Unfortunately, the mutant strains' ability to mate was seriously 
affected during mutagenesis. The strains failed to form diploids when 
crossed to strains of the opposite mating type. Mutations in the AM01 
and ,4R02 genes of Saccharomyces cerev.isiae have been reported to 
affect mating (Lucchini et al., 1978) but this seems to be a failure 
to sporulate rather than formation of diploids. It is more probable 
that one of the genes involved in mating is responsible. 
Theoretically, it should also be possible to improve the yield of 
phenylalanine by continuing rounds of mutagenesis, selecting for 
strains which crossfeed phenylalanine auxotrophs at increasing 
concentrations of , -thienylalanine. The overproducing strain finally 
obtained, however, would be a conglomeration of many different 
mutations, the genetical basis of which is unknown. In addition, it 
would contain numerous other mutations, which have not been selected 
for, affecting its general physiology in an undetermined manner. The 
above evidence also indicates that repeated rounds of mutagenesis are 
likely to lead eventually to sterile strains. A more genetically 
controlled approach may, therefore, be advantageous in the long term. 
The regulation of aromatic amino acid biosynthesis is fairly well 
understood and so it should be possible to engineer phenylalanine 
overproduction in a more directed manner by constructing regulatory 
altered yeast strains with mutations in the relevant genes. This 
approach is covered in the following chapters. 
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4. CLC4ING AND CHARACTERISATION OF THE Saxtharcxnyoes cerevisiae 
Ala:)? GENE 
4. 1 IN'ra:Duc'rIoN 
Mutant alleles exist for most of the main enzymatic steps in the 
aromatic amino acid pathway (Jones & Fink, 1981), and thus it is 
possible to isolate the genes encoding the enzymes responsible for 
each reaction using current molecular techniques. The expression of 
specific genes can then be studied in a much more direct manner than 
the classical methods used in the previous chapter. 
The aim of this section was to isolate one of the genes in the 
pathway and study its regulation in more detail, with the purpose of 
then altering its control in a manner directed towards the eventual 
overproduction of phenylalanine. 
Since other research groups were working extensively on the 
earlier sections of the pathway, especially the AR03 and ARO4 genes, 
research was concentrated on one of the lower branches of the pathway. 
The A)a37 gene codes for chorismate mutase (Kradolfer, 1977) which 
catalyses the formation of prephenate from chorismate. Since this 
enzymatic step occurs at the branchpoint where the tryptophan 
biosynthetic pathway separates from the phenylalanine and tyrosine 
pathway, it is likely that it plays a key role in the control of 
aromatic amino acid production. It is, therefore, an ideal candidate 
for the research purposes outlined above. 
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4.2 ISOLATION OF A SEQUENCE COMPLEMENTING THE aro7 MUTATION IN 
Sac.jharcwyces cerevisiae 
4.2.1 Transformation of Sac,charcxijyces cerevisiae with a Yeast Gene 
The aro7 leu2 auxotrophic strain J14-26 was transformed with 
DNA from a wild-type gene-bank (Nasmyth & Tatchell, 1980), contained 
within the shuttle vector YEp13 (see section 2.1.4). Transformants 
were selected by their ability to grow in the absence of leucine. The 
conditions used and the resulting number of transformants are 
displayed in Table 4.1 
Several controls were included: Sample 1 showed that the host 
strain could not grow without leucine and sample 2 showed that strain 
J14-26 was indeed transformable. Sample 6 was a positive control to 
show that the host strain could grow in the presence of leucine. By 
using these controls, the sixty four colonies which grew on the leir 
plates (samples 3 and 4) were identified as transformants containing a 
plasmid vector from the gene bank. 
4.2.2 Analysis of the Leu Transformants 
The sixty four IA-u transformants were screened for simultaneous 
complementation of the aro7 mutation by testing their ability to grow 
on medium lacking leucine, phenylalanine and tyrosine. Two such 
colonies were isolated. 
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TABLE 	4.1 : Results obtained from the 
transformation of the Saccharomyces cerevis.iae 
strain J14-26 with a wild-type yeast gene bank. 
Transformations were performed as described in 
section 2.4 using 5 pg DNA in each sample. 
1 0 Leu 
0 
2 YEp13 Leu 
40 
3 Gene Bank Leu 28 
4 Gene Bank Leu- 
36 
5 Gene Bank Leir Phe 	Tyr- 0 
6 Gene Bank Leu 
Complete Lawn 
Growth on complex medium relieves selection for episomal plasmids 
and these are lost from 5 to 10% of the population per generation. 
When transferred to selective media, only those colonies which have 
retained the plasmid will grow. The two colonies were streaked out 
onto YEPD plates, to obtain single colonies, and replica-plated onto 
leu- phe- tyr- plates to check that the aro7 complementing phenotype 
was conferred by the plasmid and not due to a chromosomal mutation. 
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Of the two transformants studied, one isolate did show a 
correlation between plasmid loss and loss of aro7 complementation, 
proving that the DNA complementing the aro7 mutation was carried on 
the plasmid. The other isolate, however, showed no correlation; all 
the colonies transferred from YEPD were able to grow in the absence of 
phenylalanine, tyrosine and leucine. This was probably due to 
integration of the plasmid into the yeast genome since the LE'U2 marker 
failed to segregate with the plasmid. 
4.2.3 Retransformation of yeast with pJFB1 
To confirm the wild-type AF?07 phenotype was due to the presence 
of complementing DNA cloned in the plasmid, designated pJFB1, plasmid 
DNA was extracted from a culture of the transformed strain, J14-26TR1, 
and used to retransform the aro7 auxotrophic strain J14-26. All 
transformants obtained were able to grow without phenylalanine and 
tyrosine supplementation proving that pJFB1 did indeed carry a region 
of DNA which complemented the aro7 mutation in Saccharomyces 
cerevi siae. 
The E. coli strain HB101 was transformed with pJF131 and 
sufficient plasmid DNA was obtained from a two litre culture for 
subsequent analysis. This DNA was purified by CsCl gradient 
centrifugation. 
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4.3 CONSTRUCTION OF A RESTRICTION MAP 
To localise the putative aro7 gene within the insert, it was 
first necessary to obtain a restriction map of the cloned insert. 
Twelve restriction enzymes were used; nine were found to have 
recognition sites within the DNA insert (see Fig. 4.2). The sizes of 
the digested fragments were calculated by comparison with standards 
from phage lambda DNA digested with HirtIIII, following gel 
electrophoresis. By using the known restriction sites present in 
YEp1 3, an accurate map of pJFB1 was constructed (see Fig .4.1). Any 
ambiguities were resolved by digesting with two or more enzymes 
simultaneously. 
Fig. 4.2 shows that a HirziIII digest gives four fragments of 
approximately 10.3, 3.1, 2.3 and 0.2 kb (the 0.2 kb fragment has not 
incorporated sufficient ethidium bromide to be seen), and a StüI 
digest gave two fragments of approximately 8.5 and 7.5 kb. By carrying 
out a double digest with both enzymes, the Stu I site in the insert 
was located within the 2.3 kb HiniIII fragment and the orientation of 
the HirñIII sites resolved. 
The BanI{I digest did not produce a fragment the size of the 
complete insert, showing that at least one of the original YEp13 
Bani4I sites had not been maintained. By performing a Bairk{I/HindIII 
double digest it became clear that neither site had been retained; 
both BanI-II sites being within the insert-derived 3.1 kb HithIII 
fragment. 
TABLE 4.2 Number and location of restriction 
enzyme sites in pJFB1. 
NUMBER OF RESTRICTION SITES  
ENZYME YEp13 INSERT TOTAL pJF131 
BanfII 1* 2 2 
BglII 2 1 3 
ClaI 3 3 6 
EccRI 3 2 5 
EcdW 3 1 4 
HirxIIII 2 2 4 
PS ti 3 0 3 
PvuII 1 0 1 
Sail 2 0 2 
Still 1 1 2 
XLI 1 1 2 
XhoI 1 1 2 
* Although YEp13 has a single Barn HI site, this 
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Figure 4.1 : Restriction map of 1)JFL1 
Cloned Inseil. 
Ei 	-EccAI B -Bwil-II Pv-PiII 
S - Sail Ps - PS ti St - Still 
- XhoI H - HirxlIII Bg - BgiII 
C - FV - 	F, 14"I'l - 
123456 
Figure 	4.2 	Gel 	electrophoresis 	ot 
restriction digests of pJFB1. 	1-BaniII, 
2-Banffl1HindIII, 	3-HlrriIII, 	4-HirdIII/StuI, 
5-StuI and 6-UhixiIII digested lambda DNA. 
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4.4 DELETION ANALYSIS OF pJF131 
To locate the gene responsible for complementation within the 
cloned 5.3 kb fragment, deletions were engineered in the insert and 
the resulting deletion plasmids transformed back into J14-26 and 
tested for complementation of the aro7 mutation. 
The insert is conveniently divided by HiiñIII sites into two 
fragments of 2.3 and 3.1 kb. Deletion plasinids lacking either of 
these two fragments would be helpful in locating the desired sequence. 
These were obtained by partial digestion of pJFB1 with H.irxIIII (5u4 
DNA, 5 units enzyme), followed by ligation. Gel electrophoresis of 
samples digested for 8, 16 and 30 min showed progressive appearance of 
partial digestion products 
The 30 min sample was ligated and transformed into E. coli 
strain HB101. Plasmid DNA was prepared from twenty four isolates and 
screened by gel electrophoresis for plasmids smaller than the original 
pJFB1. Eight of the isolates yielded smaller plasmids which were 
subsequently analysed for the desired deletions by HixxiIII digestion. 
As can be seen from Fig. 4.4, most of the plasmids showed a 
complete deletion of both fragments but isolate 1 had the 3.1 kb 
fragment missing while isolate 3 lacked the 2.3 kb fragment (see Fig. 
4.5). 
Plasmid DNA from isolates 1 and 3 (denoted pKH1 and pKH3 
respectively) was used to transform the Saccharainvces cerevisiae 
strain A236-57B and tested for its ability to complement the aro7 
mutation by testing for growth of the transformant in the absence of 
phenylalanine and tyrosine. 
1 	234 ,H 56 7 
Figure 4.4 : Gel electrophoresis of a HirxiIII 
digest of pJFB1 deletion plasmids. 
1. pKH1 2. pKH2 3. pKH3 4. pKH4 
A. Lambda DNA 	H. pJFB1 






























TABLE 4.3 : Deletion analysis results of aro7 
complementation test. + = growth, - = no growth, 
-* = some growth observed (see text). * () 
represents strain A236-57B transformed with the 
relevent plasmid. 
Sacxtharciuiyces cerevisiae STRAINS 
MEDIUM 	A236-57B * (pKH1) * (pKH3) 	* (pJFB1) 314 
Complete 	 + + + 	+ + 
Leu 	 - + + 	+ + 
Phe-Tyr- 	 - -* - 	+ + 
Le'.r Phe- Tyr 	- -* - 	+ + 
From Table 4.3 it can be seen that neither construct complemented 
the aro7 mutation; none of the yeast transformants were able to grow 
without phenylalanine and tyrosine supplementation. This indicated 
that the complementing sequence spans the region of the HithIII site 
at 12.7 on the pJFB1 map. 
Strain A236-57B(pKH1) showed some growth in the absence of 
leucine, phenylalanine and tyrosine but this was not correlated with 
the presence of the plasmid. The growth was in the form of papillae 
which indicates that mitotic recombination had probably taken place 
(Fogel et al., 1983). That recombination between pKHl and the AR07 
locus produces functional chorismate mutase whereas recombination 
with pKH3 was not detected, localises the original aro7 mutation 
to the 2.3 kb fragment 
M. 
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4.5.1 Preparation of RNA Filters 
Total RNA was isolated from 500 ml cultures of Saccharomyces 
cerevisiae strains 314 and J14-26TR1 and poly-adenylated mRNA 
fractions of each were separated on an oligo-dT-cellulose column. 
20 ,ug samples of total RNA and 2 ,ug of poly(A) RNA from each strain 
were run on a denaturing formaldehyde-agarose gel then transferred to 
nitrocellulose filters. 
4.5.2 Northern Hybridisation Using A 2.3 kb pJFB1 Probe 
To obtain the necessary radioactively labelled probe needed to 
hybridise with the pJFB1 transript, a Rithill digest was carried out 
on pJFB1 DNA. After gel electrophoresis, the 2.3 kb fragment was 
electroeluted, purified and nick-translated using (.4_32  P )dATP. The 
filter was hybridised for 24 h then exposed to X-ray film for 20 h. 
As can be seen from Fig. 4.6, the probe hybridised to several 
bands, all of which were represented in track 4. 
Band A was present only in tracks 2 and 4 and was, therefore, not 
polyadenylated RNA. Its very high molecular weight indicated that it 
may have been DNA contamination. 
Of the remaining bands, only C, E and F were represented in the 
poly-A tracks 1 and 3, and so may possibly have been transcripts from 
the complementing gene. 
Bands C and E clearly increased in intensity in tracks 3 and 4, 
compared to tracks 1 and 2, suggesting that the transformed strain was 







1 	2 	34. 
Figure 4.6 	Northern hybridisation with 2.3 kb 
TRACK 1 - 314 poly-A RNA 
2 - 314 total RNA 
3 - J14-26TR1 poly-A RNA 
4 - J14-26TR1 total RNA 
M. 
plasmid was present in multiple copies in the cell, this increase in 
plasmid-derived mRNA would be expected. Transcript E, however, was 
present in the poly-A RNA at much higher levels than transcript C 
which made it a much more likely candidate for the putative AR07 
transcript. 
Band F also followed the pattern expected of the pJFB1 
transcript. Since this band was rather diffuse, however, some doubt 
was expressed as to whether it was not an artifact due to degradation 
of the RNA. 
By comparison with DNA markers, the size of transcript E was 
estimated to be between 0.5 and 2 kb. 
4.5.3 Northern Hybridisation Using A 3.1 kb pJFB1 Probe 
To clarify the previous results, the Northern hybridisation 
procedure was repeated using the 3.1 kb Hi.rxllhI pJFB1 fragment. If 
this fragment contained a larger ratio of A1337 sequence to any 
extraneous gene sequences it would, possibly, only hybridise to one 
single transcript. 
Examination of the resulting autoradiograph (see Fig. 4.7) 
showed, however, that this probe also hybidised to several RNA bands 
on the filter. As with the previous probe though, only two of these 
transcripts were polyadenylated. Also in accordance with the previous 
result was the observation that the transcripts from the transformed 
strain was present in much higher quantities than those from the 
untransformed strain. This not only showed that those mRNAs were 
transcribed from plasmid DNA but indicated that the chromosomally 
encoded message was present at very low levels within the cell. 











Northern hybridisation using 3.1 kb 
TRACK 1 - J14-26TR1 total RNA 
2 - J14-26TR1 poly-A+ RNA 
3 - J14-26TR1 poly-A+ RNA 
4 - 314 total RNA 
5 - 314 poly-A+  
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Extracts of soluble proteins were prepared from the yeast strains 
314, J14-26 and J14-26TR1 grown, until late log phase, in minimal 
media containing the appropriate supplements. These were then assayed 
for chorismate mutase activity by measuring the conversion of 
chorismate to phenylpyruvate (Table 4.4). 
TABLE 4.4: Chorismate mutase activity in 
Saccharomyces cerevisiae. Data presented are the 
average of a minimum of four separate assays. 
STRAIN 	SPECIFIC ACTIVITY OF CHORISMATE MUTASE 
nmol product min- 1 (mg protein) - ' 
314 	 8.57 
J14-26 	 0 
J14-26TR1 	 24.2 
Strain 	J14-26TR1 showed a three fold increase in chorismate mutase 
activity compared to wild-type (Table 4.4). This result would have 
been expected if the strain was carrying multiple copies of the 
structural gene for chorismate mutase and hence it provided further 
evidence that pJFB1 carried the AR07 gene. As expected J14-26 had 
showed no detectable chorismate mutase activity. 
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4.7 DISCUSSION 
In summary, a fragment of DNA has been isolated from a wild-type 
yeast gene bank which complements an aro7 auxotrophic mutant of 
Saccharomyces cerevisiae. A restriction map of the plasmid pJFB1 and 
the cloned insert has been obtained and the size of the insert 
estimated to be 5.3 kb. Deletion analysis of pJFB1 has shown that the 
complementing region is located around a Hind III site 2.0 and 3.3 kb, 
respectively, from each end of the insert. Transcriptional analysis 
revealed that pJFB1 produces a 1 kb transcript which is polyadenylated 
and enzyme assays have shown an increase in chorismate mutase activity 
in the aro7 auxotrophic strain transformed with pJFB1. 
As pointed out by Nasmyth and Reed (1980), complementation of a 
mutation in a specific gene by a cloned sequence is not sufficient 
proof that this sequence corresponds to the gene being sought. For 
genes cloned by complementation it is necessary to demonstrate that 
the fragment codes for the wild-type gene and not a phenotypic 
suppressor. 
The defect in the AF37 gene of strain J14-26 is a nonsense 
mutation, which results in the premature termination of translation 
(B. Carter, personal communication) and, therefore, could be 
suppressed by an altered tRNA which would read through this stop 
codon. There are, however, several lines of evidence to suggest that 
this has not happened. 
First, pJFBI produces a transcript which is polyadenylated and 
approximately the correct size to code for the chorismate mut.ase 
protein. This suggests that it is mRNA and not tRNA since the latter 
is not polyadenylated. 
Secondly, in the strain J14-26TR1, the increase in chorismate 
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mutase activity above the level displayed by wild-type cells cannot be 
explained by the presence of a suppressor tRNA. A suppressor would be 
unlikely to increase the activity of a mutant strain above its 
original wild-type level. The possibility of having cloned a positive 
regulator of chorismate mutase can also be ruled out since this would 
not complement an aro7 mutation of this nature. 
Thirdly, transformation of strain J14-26 with pJFB1 confers upon 
the cells an increased resistance to the phenylalanine analogue 
-thienylalanine, compared to non-transformed strains (K.Linton, 
personal communication). This implies that multiple copies of the 
complementing gene within the cell result in a greater production of 
phenylalanine than found in wild-type cells, a property not readily 
associated with a tRNA suppressor. 
Fourthly, the met4 mutation of strain J14-26 was also an amber 
mutation but it was not complemented by pJFB1 (K.Linton, personal 
communication). 
Finally, the deletion plasmid pKH1 recombined with the original 
aro7 mutation to produce a functional enzyme. Such a recombination 
event would only take place at a region of homology between the insert 
and the chromosomal AR07 locus and so implies that pKH1 and hence 
pJFBI carries the wild-type AM07 gene. 
All of these points indicated that pJFB1 contains the stuctural 
gene for chorismate mutase but they are not conclusive. Proof that a 
fragment actually codes for the complemented gene is generally 
demonstrated by showing that a plasmid containing the fragment 
integrates at the corresponding chromosomal locus and shows genetic 
linkage to the gene. Construction of an integrating vector and 
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subsequent integration experiments would, therefore, have been the 
next logical step in proving that the AF07 gene had been cloned. 
While attempting to do this, however, Wickner and his collegues 
reported that they had also cloned the A7 gene (Ball et al., 1986). 
Comparison of the restriction map of their plasmid (YpAR7-1) with 
pJFB1 revealed a large region of homology within the insert, proving 
that the cloned region complementing the aro7 mutation was the same, 
although the actual orientation was reversed. 
Wickner's group had shown that their cloned gene integrated at 
the chromosomal AR07 locus. Since the pJFB1 insert shared a homologous 
DNA region with YpAR7-1 it was not necessary to perform any 
integration experiments to conclude that pJFB1 definitely contained 
the structural A7 gene. 
More information on the localisation of the AR07 gene was 
obtained from Hutter's group who were also working with YpAR7-1. They 
obtained full chorismate mutase activity from a plasmid containing the 
2.7 kb BgiII - ClaI fragment while the 1.8 kb Clal fragment gave 
only partial activity (T. Schmidheini, personal communication). This 
suggested that the promoter was located around the ClaI site at 12.4 
on the map. The direction of transcription would, therefore, be from 
left to right (see Fig. 4.8). 
Alternatively, transcription might be in the opposite direction; 
the deletion may have removed part of the stuctural gene and thus 
produced a slightly less active form of the protein. This is unlikely, 
however, due to the location of the original nonsense mutation within 
the 2.3 kb Hirdlil fragment. Unless the mutation is situated between 
the Cia! site at 12.4 and the Hithill site at 12.7, transcription in 
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this direction would result in the improbable situation that although 
the 1.8 kb Cla.I fragment displays partial chorismate inutase activity, 
the longer polypeptide synthesised by original mutant strain displays 
no enzyme activity at all. 
Wjckner found full chorismate mutase activity with a 2.4 kb 
Sau3A partial digestion fragment (Ball et al., 1986) but a detailed 
location of this fragment was not given, although it did span the 
0.9 kb HirxiIII - Eco RI region. More information was needed, 
therefore, before precise localisation of the gene and direction of 
transcription could be conclusively resolved. 
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No Activity 	 No Activity 	 I 
Figure 4.8 : Map of pJFB1 insert containing 
the ATh7 gene. The levels of chorismate mutase 
activity, determined by complementation 
analysis, shown by different subclones are 
indicated. 
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5. ISOLATION AND ANALYSIS OF aro7 RE(JJLAY &TJAWFS 
5. 1 INTRODUCTION 
Having cloned the AR07 gene from Saccharoniyces cerevisiae, 
further molecular genetic analysis such as DNA sequencing could have 
been applied. It was considered important, however, not to lose sight 
of the original purpose of isolating the gene, which was to alter its 
regulation in a manner condusive to phenylalariine overproduction. 
Although multiple copies of the A1307 gene in the cell resulted in 
enhanced chorismate mutase activity, the enzyme should still be 
regulated by feedback inhibition by tyrosine. Any tendency towards 
increased phenylalanine production would be counteracted by the 
excess tyrosine also produced inhibiting the activity of the enzyme. 
Therefore, a yeast strain resistant to this feedback inhibition by 
tyrosine was required. 
The aim of this section was to isolate regulatory mutants of AR07 
by in vitro muta,genesis of pJF131. During in vitro mutagenesis the only 
gene subject to mutation is the desired target gene and this 
procedure, therefore, offered a more specific and direct way to enrich 
for feedback-resistant mutations. 
A mutation in the AF07 gene resulting in feedback insensitive 
chorismate mutase would be advantageous in several ways. Not only 
would it facilitate the overproduction of phenyalanine but the 
information obtained by analysing the phenotypes of the various 
regulatory mutants may result in a fuller understanding of the 
regulation of aromatic amino acid biosynthesis in Saccharomyces 
cerevis.iae. 
5.2 ISOLATION OF aro7 RFULA1Y MUTANTS 
5.2.1 In Vitro Mutagenesis of PJF131 
400 lug 	pJFB1 	were 	treated 	with 	the 	mutagen 
O-methylhydroxylamine, which induces C-T transitions in DNA. The AI37 
auxotrophic yeast strain J14-26 was then transformed with the mutated 
plasmid and transformants were selected by their ability to grow in 
the absence of leucine. 
The frequency of transformation was very low (Table 5.1). The 35 
Leu4  transformants were replica plated onto media lacking phenylalanine 
and tyrosine to check if they still complemented the AF?07 gene. 24 
transformants were able to grow without phenylalanine and tyrosine 
supplementation, the remaining eleven had probably lost chorismate 
mutase activity completely. 
TABLE 5.1 : Number of transformants obtained in 
the transformation of yeast strain J14-26 with in 
vi tro mutated (m) pJFB1. 
DNA SE 	 TRANSF1A 
1] 
5 pg pJFB1 
2 pg pJFB1(m) 










5.2.2 Selection of Regulatory Mutants 
Mutants with feedback resistant chorismate mutase should contain 
elevated phenyalanine and tyrosine pools and, therefore, show 
increased resistance to analogues of these amino acids. This 
rationale formed the basis of the selection method used to isolate 
regulatory mutants of AR07. 
The 24 Aro' colonies transformed with the mutated pJFB1 were 
transferred to media containing a range of concentrations of 
frthienylalanine and 5-methyltyrosine and checked for an increase in 
analogue resistance compared to the wild-type transfonnant J14-26TR1. 
Nine of the transformants showed an increased resistance to the 
phenylalanine analogue ,B-thienylalanine and were able to grow at a 
concentration of 50 mg ml which is inhibitory to the mutant 
transformed with the wild-type plasmid (Fig. 5.1). No significant 
increase in resistance to 5-methyltyrosine was detected. 
This phenotype was correlated with the presence of the plasmid by 
plasmid-loss experiments and retransformation. Strain 2, however, 
retained its resistant phenotype in all colonies, after growth on 
complex medium, and failed to retransform. Further analysis of --ts 
genotype revealed that it did not contain any of the auxotiphic 
markers carried by the original J14-26 brain. It was, therefore, 
assumed to be a contaminant. 
Figure 5.1 : Growth of J14-26 transformed with in 
vitro mutated pJFB1 on different concentrations of 
-thieny1a1anine. 
 Opg ml- ' 
 50pgml- ' 
C - 100 pg m1' 
D - 250 pg ml- ' 
E - 500 pg ml- ' 
wt - wild-type 
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5.3 REGUIATION OF dHI1ATh !'LTFASE AFIVITY IN Saharyoes 
cerevisiae 
The four regulatory mutants which displayed the greatest increase 
in resistance to-thienylalanine (J14-261V3, J14-261V5, J14-261V6 and 
J14-261V9) were used, along with J14-26TR1, containing the wild-type 
pJFB1, and the wild-type strain 314 to assay chorismate mutase 
activity under a variety of conditions. Unless otherwise stated, each 
result was the average of at least four repetitions of the assay 
concerned. 
5.3.1 Effect of Tyrosine 
Extracts of soluble proteins from the above strains were assayed 
fur ehorisiiiate utasc acivity in the prerw'e of a range of 
concentrations of tyrosine. The results are presented graphically in 
Figs. 5.2A and 5.2B. 
Graph A shows that both strains displayed feedback inhibition of 
chorismate mutase by tyrosine. Strain J14-26TR1 had a higher initial 
activity and was not inhibited to the same degree as 314, still 
showing some activity at 5 mM tyrosine. The transformed strain carries 
multiple copies of the AF7 gene and thus produces more chorismate 
mutase, feedback inhibition, therefore, would not be so effective as 
with an nontransformed strain, at a given concentration of tyrosine. 
Graph B shows the effect of tyrosine on the four strains 
representing possible regulatory mutants of AR07. All four strains 
showed inhibition by tyrosine but to different extents. As the 
concentration of tyrosine increased, both J14-261V5 and J14-261V6 
displayed a decrease in chorismate mutase activity similar to that of 
































TYROSINE 	CONC. (mM) 
appeared to have an increased resistance to inhibition by tyrosine, 
showing half their initial level of activity at 5 mM tyrosine 
compared to a decrease by a factor of approximately 10 in the other 
strains. These results indicate that these two strains contain 
mutations in the AF?07 gene which render it resistant to feedback 
inhibition by tyrosine. 
5.3.2 Effect of Tryptophan 
The above experiment was repeated, this time assaying chorismate 
mutase activity in the presence of a range of tryptophan 
concentrations. 
Fig.5.3 shows that tryptophan had vitually no effect on 
chorismate mutas activity, over the range of concentrations used. This 
result was surprising since tryptophan had previously reported to 
activate the enzyme (Jones & Fink, 1982), so an increase in activity 
was expected. Other groups, however, had stated that rather than 
stimulating chorismate mutase activity, tryptophan counteracts the 
inhibition by tyrosine (Miozzari et al.,1978). To resolve these 
contradictory results, the effect of both tyrosine and tryptophan on 
chorismate mutase activity was studied in all six strains. 
Graph A in Fig.5.4 clearly shows that, in the wild-type strain, 
tryptophan did overcome the inhibitory effect of tyrosine; the extent 
to which it counteracted inhibition increasing with tryptophan 
concentration. Strain J14-26TR1, represented in graph B, also showed 
this reduction in tyrosine inhibition although to a lesser extent, 
with 5 mM tyrosine still causing inhibition even at levels of 5 mM 
tryptophan. In the wild-type strain 314, 5 mM tryptophan practically 
abolished tyrosine inhibition, chorismate mutase activity was restored 
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Figure 5.3 	Levels of chorisrnate mutase activity 
displayed by various yeast strains assayed in different 
















TRYPTOPHAN 	CONC. (mM) 
RAI 
Figure 5.4 	Levels of chorismate mutase activity 
displayed by various yeast strains assayed in different 
concentrations of tyrosine and tryptophan. 
Graph A - 314 
Graph B - J14-26TR1 
Graph C - J14-261V9 
0 	0 mM Tryptophan 
L 2.5 mM Tryptophan 












































TYROSINE 	CONC. (mM) 
C 
to its original level seen at 0 and 5 mM tyrosine. 
Since J14-261V9 appeared to be resistant to feedback inhibition 
by tyrosine, there was the possibility that tryptophan may, in 
counteracting inhibition, have led to a further increase in chorismate 
mutase activity. The results displayed in Fig. 5.3 showed that 
tryptophan had very little effect on chorismate mutase but when 
tyrosine was present (Fig.5.4C) there was a very slight increase in 
enzyme activity. Since the data was the result of only two assays, 
however, it was doubtful whether this increase was significant. 
5.3.3 Effect of Tyrosine on a Tryptoythan Prototrophic Strain 
The yeast strain J14-26 carries a mutation in the TRP1 gene, therefore 
supplementation with tryptophan was necessary- Tiyptophan was shown to 
affect tyrosine inhibition, so the additional tryptophan in the media 
may have been affecting the results obtained in these studies, making 
comparisons between strains less easy to interpret. The plasmid pJFB1 
was, therefore, transformed into the tryptophan prototrophic strain 
SF747-19D and the effect of tyrosine on chorismate mutase activity 
analysed (Fig.5.5). 
No significant difference in tyrosine inhibition was found 
between tryptophan auxotrophic and prototrophic backgrounds. As 
expected the untransformed SF7 47-19D showed a reduction in chorismate 
mutase activity with increasing tyrosine concentration similar to that 
displayed by 314. 
Chorismate mutase activity in SF747-19D carrying pJFB1 was also 
inhibited in a manner similar to J14-26TR1. The presence of tryptophan 
in the growth media, therefore, did not affect tyrosine inhibition. 
Presumably this was because it was present in quantities just 
Figure 5.5 	Levels of chorismate mutase activity 
displayed by tryptophan prototrophic yeast strains assayed 


















sufficient to allow growth. Also, if there was any exogenous 
tryptophan this would be removed during the initial washes. 
5.3.4 Effect of Phenylalanine 
The mutant pJFB1 plasmids were selected on the basis of 
conferring increased 1B-thienylalanine resistance to their host yeast 
strain. This was, presumably, due to the transformed strains 
overproducing phenylalanine. Therefore, the possibility that 
chorismate mutase was regulated in some way by phenylalanine was 
investigated. 
Fig.5.6 shows the results from chorismate mutase assays carried 
out over a range of phenylalanine concentrations. Over the range 
used, phenylalanine had very little effect on chorismate mutase 
activity; there was a slight decrease in activity in strain J14-26TR1 
which was not shown in strain J14-261V9 but since 314 was not affected 
it was unlikely that this decrease represented inhibition by 
phenylalanine. 
5.4 REGULATION OF AI07 FXPRS ION IN Sax,harc,nyces cerevisiae 
In addition to the inhibition or activatoin of enzyme activity, a 
metabolic pathway may be regulated by controlling the transcription 
rate of specific genes. Expression of the ATh97 gene was studied by 
assaying chorismate mutase activity in various yeast strains grown in 
the presence of the appropriate amino acids. These added amino acids 
were removed before assaying, therefore any alteration in chorismate 
mutase activity was due to a change in the amount of enzyme produced. 
Figure 5.6 : Levels of chorismate mutase activity 
displayed by various yeast strains assayed in different 























5.4. 1 Effect of Tyrosine 
Strains 314, J14-26TR1, J14-261V3, 5, 6 and 9 were grown in 
minimal media containing different cocncentratiqns of tyrosine, plus 
appropriate amino acid supplements. The cells were washed several 
times to remove exogenous amino acids before assaying for chorismate 
mutase. The results are represented graphically in Fig. 5.7. 
As the concentration of tyrosine in the growth medium was 
increased, there was a corresponding decrease in chorismate activity 
(Graph A). The tyrosine was removed before the activity was measured 
so the reduction in activity was unlikely to be caused by inhibition 
but due to a decrease in the actual amount of enzyme present. Therefore, 
tyrosine was probably repressing transcription of the AR07 gene. 
Overepression of AR07, in J14-26TR1, led to the production of higher 
levels of enzyme at all tyrosine concentrations but repression was 
still seen. 
Fig. 5.7B shows the effect of incresing the concentration of 
tyrosine in the medium on the chorismate mutase activity of the 
mutated strains. Both J14-261V3 and J14-261V5 seem to be repressed by 
tyrosine in a similar manner to the unmutated strain. J14-261V6 and 
J14-261V9, however, appeared to be resistant to this effect, showing 
no appreciable decrease in activity with increasing tyrosine 
concentration. 
5.4.2 Effect of Tryptophan 
Chorismate mutase activity was studied in the three strains, 314, 
J14-26TR1 and J14-261V9, this time grown in various concentrations of 
tryptophan. (The concentrations of tryptophan cited do not include the 
low level of tryptophan supplement ( 10 mgi'), required by strains 
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Figure 	5.7 : 	Levels 	of chorismate 	mutase activity 
displayed by various 	yeast strains 	grown 	in different 




































J14-26TR1 and 1V9) 
Fig.5.8 shows that tryptophan caused a very slight increase in 
chorismate mutase activity in all three strains. There was, however, 
considerable variation in the values for addition of 5 mM tryptophan 
hence it was doubtful whether this increase represented a valid 
increase in AR07 expression. Lingens et al. (1967) described an 
induction of AR07 expression but this could not be confirmed by later 
work (Kradolfer, 1977). 
Since tryptophan had been shown to counteract inhibition by 
tyrosine, the same three strains were grown in the presence of both 
tyrosine and tryptophan to find out whether tryptophan also reduced 
tyrosine repression (Fig.5.9A). With strain 314, tryptophan had little 
effect on the rate of tyrosine repression, although higher enzyme 
tryptophan 
activity was noticed with increasing 	concentration, at all 
levels of tyrosine. Strain J14-26TR1 showed similar results (Graph B) 
while J14-261V9 still appeared to be resistant to the repression 
effect. It also showed no increase in activity with increased levels 
of tryptophan. 
5.4.3 Effect of Phenylalanine 
Chorismate mutase was assayed over a range of phenylalanine 
concentrations (0 to 5 mM) in the growth media but no significant 
change in AF07 expression was observed (Fig.5.10) since all strains 
displayed an approximately constant level of activity over the range 
of phenyalanine concentrations used. 
Figure 5.8 	Levels of chorismate mutase activity 
displayed by various yeast strains grown in different 




Tryptophan concentrations do not include the 
additional 0.1 mM tryptophan supplement required 
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Figure 5.9 : Levels of chorismate mutase activity 
displayed by various yeast strains grown in different 
concentrations of tyrosine and tryptophan. 
Graph A - 313 
Graph B - J14-26TR1 
Graph C - J14-261V9 
0 	0 mM Tryptophan 
2.5 mM Tryptophan 
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Figure 	5. 10 : 	Levels 	of chorismate 	mutase activity 
displayed by various 	yeast strains 	grown 	in different 
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W. 
The mutant colonies were isolated on the basis of their increased 
resistance to the phenylalanine analogue -thienylalanine. This is, 
probably, due to the various strains producing increased levels of 
phenylalanine compared to the wild-type strain. 
The amino acid content of extracellular supernatants from the 
various strains, grown with and without additional tyrosine 
(50,k4 ml - 1 ) in th& media, was analysed by thin layer chromatography, 
in an attempt to identify and quantitate the phenylalanine. 
All the mutated strains showed detectable levels of phenylalanine 
excreted into the medium (between 0.01 and 0.1 mg ml -1 ). Phenylalanine 
was not detected in the supernatants of 314 and J14-26TR1 indicating 
that the regulatory mutants are overproducing phenylalanine. The 
supernatants of the mutant strains grown in the presence of tyrosine 
showed a small increase in phenylalanine excretion although the amount 
was still less than 0.1 mg m1 1 . This increase in phenylalanine 
production is, presumably, due to the excess tyrosine inhibiting 
prephenate dehydrogenase (see Fig. 1.2), making more prephenate 
available for phenylalanine biosynthesis. 
5.6 DISCUSSION 
Several regulatory mutants of AJ07 have been isolated. The 
phenotypes of the four strains analysed can be summarised as follows: 
J14-261V3 showed a partial resistance to feedback inhibition by 
tyrosine while J14-261V6 appeared to have an increased resistance to 
tyrosine repression. J14-261V5 displayed characteristics similar to 
and repression 
the unmutated J 1 4-26TR1, being subject to both inhibition by tyrosine. 
J14-261V9, however, showed resistance to tyrosine repression and 
possibly resistance to inhibition as well. 
It is not yet known whether tyrosine acts as a competetive or 
non-competetive inhibitor of chorisinate mutase. Research in E. coli 
(Christopherson, 1985) suggests that it interacts with the substrate 
binding site, however, extrapolation to yeast is complicated by the 
fact that, in E. coli, chorismate mutase is part of a bifunctional 
protein which also incorporates prephenate dehydrogenase activity 
(Camakaris & Pittard, 1983). 
If tyrosine does bind to the active site then any mutation 
reducing its binding may also affect the binding of the substrate and 
hence reduce tha activity of the enzyme. This was observed in the 
mutant strains J14-261V3 and 1V9. These strains both showed resistance 
to inhibition by tyrosine but their initial level of activity was much 
lower than that displayed by the unmutated strain. Alternatively, 
tyrosine may bind to an allosteric site which has been altered in the 
mutants, reducing their capacity to bind tyrosine. Depending on the 
nature of the conformational change, this could also affect the 
enzyme's affinity for chorismate and reduce its activity. 
The most likely mechanism for loss of inhibition is by 
introducing a mutation into the stuctural gene for the enzyme 
concerned. The feedback-resistant mutants were obtained by in vitro 
mutagenesis of pJFB1 and so provide strong evidence that the plasmid 
carries the structural gene for chorismate mutase in Saccha.romyces 
cerevisiae. 
A surprising result was the observation that addition of 
tryptophan to the assay mixture did not actvate chorismate mutase to 
any significant extent. Other groups had reported a 20-27 fold 
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increase in enzyme activity in the presence of 1 mM tryptophan 
(Kradolfer et al., 1977; Ball et al., 1986). In strain J14-26TR1 this 
lack of activation could be due to the tryptophan present in the 
medium causing maximum enzyme activity throughout. Strain 314, 
however, was not supplemented with tryptophan so an increase in 
activity would be expected on the addition of tryptophan. 
In contrast to the above reports it was noticed, however, that 
tryptophari counteracted inhibition by tyrosine. In strains 314 and 
J14-26TR1, the enzyme activity in cells grown in 2.5 mM tryptophan, 
5 mM tyrosine was reduced by 50 and 25% respectively compared to a 
complete loss of activity when no tryptophan was present. Tryptophan 
restored the slight loss of activity in J14-261V9 but did not increase 
it, to any significant extent, beyond its original (no additional 
tyrosine or tryptophan) level. 
Phenylalanine had been reported to play a role in the regulation 
of chorismate mutase in several species (Gething & Davidson, 1977; 
Singh et al., 1985) but showed no detectable effect on enzyme activty 
in the Saccharom,vces cerevisiae strains used. 
Strain J14-261V9 displayed resistance to feedback inhibition by 
tyrosine and was selected on the basis of its increased resistance to 
frthienylalanine 1  an analogue of phenylalanine. This strain showed, at 
the concentrations used, no increase in resistance to 
5-methyltyrosine, compared to the unxnutaed strain, and so indicates 
that it is overproducing more phenylalanine than tyrosine. The 
conversion of chorismate into prephenate, catalysed by chorismate 
mutase, is the last step in the common phenylalanine/tyrosifle 
biosynthetic pathway. Prephenate is subsequently converted into 
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phenylpyruvate and 4-hydroxyphenylpyruvate by prepheriate dehydratase 
and prephenate dehydrogenase respectively (Jones & Fink, 1982). 
Prephenate dehydratase, encoded by the PHA2 gene, has a higher 
affinity for prephenate than the dehydrogenase (Jones & Fink, 1982)) 
and so phenylalanine is preferentially synthesised. This alone may 
explain the increase in phenylalanine production although excess 
phenylalanine is reported to inhibit prephenate dehytiratase. The 
overproduction, therefore, may be due to the flux through this pathway 
being more sensitive to the increase in prephenate than the flux 
through the tyrosine pathway. 
Although the aim of these experiments was to isolate mutants 
resistant to feedback inhibition by tyrosine, the analysis of the 
mutants obtained has revealed much information not only on the 
regulation of chorismate mutase activity but also on the control of 
ATh)7 expression. The most interesting of these being the fact that, as 
well as chorismate mutase being inhibited by tyrosine, its production 
appears to be repressed by tyrosine. Tyrosine mediated repression of 
chorismate mutase has been well documented in E. col.i (Camakaris & 
Pittard, 1983; Hudson & Davidson, 1984) but not considered to operate 
in yeast, inhibition being cited as the major control process (Lingeris 
et a]., 1967). 
Two of the mutants studied, J14-261V6 and 1V9 showed resistance 
to this repression. Strain J14-261V9 also showed resistance to 
inhibition by tyrosine. This indicates that the AI07 gene on this 
plasmid probably contains at least two separate mutations; one in the 
structural gene affecting its conformation and another in its 
upstream regulatory sequences. This is not unlikely since treatment 
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with 0-methy1hydroxylalnine in vi tro probably causes several random 
mutations throughout the plasmid. 
These results do not prove conclusively that the decrease in 
chorisnate mutase activity is caused by a reduction in A1)7 
expression, many other factors including post-translational 
mothf cation must be taken into consideration. The existence of these 
"repression" resistant mutants, therefore, will be advantageous in 
analysing this effect further and facilitate a more thorough 
understanding of the regulation of A1337 expression. 
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6 TRANSCRIPTIONAL ANALYSIS OF ThE AJ07 GENE IN Sacchararnyces 
cerevisiae STRAINS J14-26TR1 AND J14-261V9 
6. 1 INTRODUCTION 
Although the regulatory mutants were isolated with the aim of 
overproducing phenylalanine, analysis of their phenotypes revealed 
many new aspects to the regulation of the AF?07 gene. With the 
withdrawal of G.D. Searle from the project, however, the pressure to 
concentrate research on phenylalanine overproduction was removed and 
hence it was considered important to study the tyrosine repression 
phenómenom in more detail. The main point to ascertain was whether the 
decrease in chorismate mutase activity was due to tyrosine illiciting 
a decrease in the actual transcription of the AFJ7 gene and, if so, 
was transcription of the repression-resistant gene unaffected ? This 
was answered by directly investigating the effect of tyrosine on ATh07 
transcription in both the wild-type strain J14-26TR1 and the mutated 
strain J14-261V9, which displayed resistance to both repression and 
inhibition by tyrosine. 
6.2 NCEflIERN ANALYSIS AND HYBRIDISATION 
Total RNA was isolated from 250 ml cultures of Saccharomyces 
cerevisiae strains J14-26TR1 and J14-261V9 grown in a range of 
concentrations of tyrosine (0 to 5 mM). 20 ,ug RNA samples from each 
strain were run on a denaturing formaldehyde/agarose gel and then 
tranferred to nitrocellulose filters. 
The additional information on the localisation of the A1307 gene 
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within pJFB1 (T. Schmidheini, personal communication) allowed the 
construction of a more specific DNA probe. The probe was obtained by a 
StuI/Ban}lI double digest of pJFB1 and subsequent isolation of the 
3.1 kb insert-derived fragment which was nick-translated using 
This fragment spans the HirxiIII site known to be in the 
structural gene and possibly has less extraneous DNA at either end 
It therefore has an increased likelihood of hybridising specifically 
to AJ07 mRNA, compared with previous probes. 
The filter was hybridised with this probe for 36 h and then 
exposed to X-ray film for 20 h. 
As can be seen from Fig.6.1, the probe only hybridised to one 
band, assumed to be the A107 transcript. In lanes 1 to 4 there is a 
decrease in the intensity of the bands indicating that there is less 
rnRNA present. It appears, therefore, that tyrosine is repressing the 
transcription of the wild-type ATh07 gene in strain J14-26TR1. 
The band in lane 5, representing the transcript produced from 
strain J14-261V9, had an increased intensity indicating that there was 
a larger amount of mRNA present compared to the other lanes. It was 
deduced, therefore, that the mutant A107 gene in J14-261V9 has an 
increased level of transcription. 
Preliminary analysis revealed that the levels of the AI07 
transcript in this mutant strain did not decrease significantly as 
the concentration of tyrosine in the growth media increased but more 
substantial evidence was required. 
6.3 ANALYSIS OF TRANSCRIPTION USING THE SLOT-BLOT METhOD 
One of the advantages of isolating a specific AF?07 probe which 
hybridised to a single transcript was that further transcriptional 
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Figure 6.1 : Northern hybridisation of 3.1 kb 
StuI/RanilI pJFB1 fragment to total RNA from 
J14-26TR1 grown in different tyrosine 
concentrations. 
TRACK 1 - 0 mM tyrosine 
2 - 1.0 mM 
3 - 2.5 mM 
4 - 5.0 mM 
5 - J14-261V9 total RNA 
0 mM tyrosine 
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analysis could be performed using the Amersharn "Hybri-slot" 
apparatus. In this "slot-blot" procedure discrete amounts of RNA are 
applied directly to the nitrocellulose filter without the requirement 
for gel electrophoresis. Since the probe is specific for the AJ07 
transcript, any changes in the intensity of the hybridised band can be 
assumed to be due to changes in the amounts of AF?07 jnRNA present. 
A filter containing 20,*ig aliquots of denatured RNA, isolated 
from strains J14-26TR1 and J14-261V9 grown under different 
concentrations of tyrosine (see 6.2), were probed with the 
radioactively labelled 3.1 kb Banf{I/StuI pJFB1 fragment. A second 
similar filter was probed with the radioactively labelled plasmid 
pSP65 which carries the gene encoding 18 S rRNA (see 2.1.5). 
Transcription of the 18S rR.NA gene should not be affected by changing 
the concentration of tyrosine present in the media and hence remain at 
a constant level throughout. The levels of rRNA are, therefore, 
indicative of the total amounts of RNA present. Comparison between 
the two filters would, therefore, indicate whether any decrease in 
AR07 mRNA levels is due to a decrease in the transcription of the gene 
or caused by discrepancies in the total amount of RNA in the sample. 
The filters were hybridised for 48 h and then exposed to X-ray 
film for 16 h. 
The resulting autoradiograph (Fig. 6.2) showed that the amount of 
AR07 mRNA produced by J14-26TR1 decreased with increasing tyrosine 
concentration while the AR07 transcript from the mutated strain 
J14-261V9 did not show this decrease. The levels of rRNA did not show 
any corresponding decrease in intensity, remaining at an approximate 
constant level in both strains. 
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Figure 6.2 	: Transcriptional analysis using the slot-blot 
hybridisation method. 
A - 20 pg total RNA from J14-26TR1 grown in (1) 0 mM, (3) 2.5 mM 
and (4) 5 mM tyrosine, probed with 3.1 kb pJFB1 fragment. 
B - As above with 0.2 pg RNA 
C - 20 ug total RNA from J14-261V9 grown in (1) 0 mM, (2) 1 mM, 
(3) 2.5 mM and (4) 5.0 mM tyrosine, probed with 3.1 kb pJFB1 
fragment. 
D - As above with 0.2 pg RNA 
E - As A probed with 18S rRNA probe. 
F - AsB 
G - AsC 
H - AsD 
Figure 6.3 : Densitometer scan corresponding to 
rRNA probe hybridisation in Fig. 6.2. 
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densitometer (Loebi Chromoscan 3). Specific peaks were cut from the 
resulting graphs (see Fig. 6.3) and weighed, their weight being 
proportional to the area under the curve and, therefore, 
representative of the intensity of the bands. By assigning numerical 
values to specific bands, a more accurate estimate of the relative 
levels of AR07mRNA and rRNA could be calculated (Table 6.1). 
TABLE 6.1: Levels of AI07mRl4A relative to rRNA. 
Data is standardised relative to the value 
obtained for J14-26TR1 under conditions of no 
additional tyrosine. 
TYROSINE CONC. (ntl) J14-26TR1 J14-261V9 
0 	 1.00 	2.12 
	
2.5 	 0.62 	1.93 
5.0 	 0.07 	3.60 
In strain J14-26TR1 the level of AF07 mRNA decreased considerably 
as the concentration of tyrosine present in the medium increased. The 
amount of transcript present at 5 mM tyrosine being approximately ten 
fold lower than the level produced under conditions of no additional 
tyrosine. This indicates that tyrosine was repressing the expression 
of the AF?07 gene. 
The strain J14-261V9, containing the mutated plasmid, did not 
show this decrease but a slight increase in the transcript at 5 m.M 
tyrosine was noted. This implies that the strain is resistant to 
repression by tyrosine. 
When the levels of AR07 mRNA produced by each strain under 
conditions of no additional tyrosine were compared it was observed 
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that strain J14-261V9 was producing approximately twice as much 
transcript as J14-26TR1, indicating that there was an increase in the 
expression of the gene in the mutated strain. This is in agreement 
with observations made with the Northern analysis. 
6.4 ANALYSIS OF PLASMID COPY NUMBER 
Although the previous section showed that ARO7 mRNA decreased 
with increasing tyrosine concentration, this was not conclusive proof 
that tyrosine was repressing transcription of the ARO7 gene. The AR07 
gene is present on an episomal plasmid and hence the level of A1307 
mRNA within the cell is not just a function of the transcription rate 
of the gene but also of the number of copies of the AR07 gene within 
the cell. Any factor causing a change in the copy number of the 
plasm.id would, therefore, cause a corresponding change in the levels 
of A.R07 mPNA. This "repression" by tyrosine could, therefore, be due 
to the additional tyrosine causing a decrease in the muber of copies 
of pJFB1 within the cell. 
Total DNA was prepared from 100 ml cultures of the strain 
J14-26TR1 grown in minimal media (plus appropriate supplements) 
containing 0, 2.5 and 5 mM tyrosine respectively. 1 pg aliquots of 
each sample were electrophoresed on a 0.7% agarose gel. The ratio of 
plasmid to chromosomal DNA was calculated by densitometry, outlined in 
the previous section (Table 6.2). 
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TABLE 6.2 	Amount of pJFB1 within the cell 
relative to total DNA. Results are standardised 
relative to the value obtained with J14-26TR1 
under conditions of no additional tyrosine. The 
data presented are the average of three separate 
aliquots of each sample. 
TYLJSINE CONC. (nil) J14-26TR1 J14-261V9 
	
0 	 1.00 	0.92 
2.5 	 1.25 	0.75 
5.0 	 1.35 	0.60 
The number of copies of pJFB1 did not decrease with increasing 
tyrosine concentration (Table 6.2). There was a slight increase in the 
amount of plasmid DNA relative to chromosomal DNA but this was 
probably due to discrepancies during the preparation of the DNA rather 
than a significant increase in the plasmid copy number. 
Fluctuations in plasmid copy number could also be responsible 
for the phenotype of strain J14-261V9. If mutagenesis of the plasmid 
had resulted in a mutation which caused tha amount of plasmid to 
increase with increasing tyrosine concentration, then this would 
result in the cell being less sensitive to tyrosine repression and so 
account for the apparent constant level of AR07 MR-NA. The above 
experiment was repeated, therefore, using DNA from strain J14-261V9 
grown in the presence of different concentration of tyrosine (0 to 
5 mM). No increase in plasmid DNA relative to total DNA was noted 
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(Table 6.2). 
When the relative amounts of pJFB1 present in each strain, under 
conditions of no additional tyrosine were compared, the two values 
were approximately equal, indicating that the initial copy number was 
the same in each case. 
6.5 DISCUSSION 
In summary, direct analysis of mRNA levels 	 in 
the Saccharonwces cerevisiae strains J14-26TR1 and J14-261V9 has 
revealed that increasing the concentration of tyrosine present in the 
medium resulted in a decrease in the level of transcript produced. A 
decrease in the copy number of pJFB1 was not responsible for this 
decrease in transcript level since this remained approximately 
constant throughout the increase in tyrosine concentration. This 
indicates, therefore, that tyrosine is repressing the transcription of 
the AW7 gene. 
In strain J14-261V9, however, this repression was not observed; 
the level of the AR07 transcript did not decrease with increasing 
tyrosine concentration. The level of plasmid within the cell did not 
increase and hence was not responsible for the maintenance of AR07 
mRNA levels. This implies that the in vitro mutagenesis of pJFB1 with 
Omethylhydroxylamine resulted in a mutation in the A1337 gene 
rendering it resistant to repression by tyrosine. By the nature of its 
phenotype, this mutation probably lies within the regulatory DNA 
sequences situated upstream from the structural gene. Assuming that 
repression is effected by a protein molecule binding to the DNA and so 
preventing transcription of the gene, the mutation is likely to be an 
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alteration in the DNA sequence of the binding site, rendering it 
unable to bind the repressor effectively. 
It was also noted, in both the Northern and slot-blot analysis, 
that the mutated strain J14-261V9 produced higher levels of Ai07 mRNA 
than J14-26TR1 when no extra tyrosine was added. Comparison of plasmid 
copy number showed no difference between the two strains and hence it 
was concluded that mutagenesis of the plasmid pJF131 had resulted in 
increased expression of the AR07 gene. 
This increased rate of transcription may be the result of the 
original mutation which conferred resistance to repression, or it may 
be caused by a second mutation in an independent control region of the 
AR07 gene. The latter is more probable since the former assumes a 
basal level of repression, even in the absence of additional tyrosine. 
The enhanced expression of the AR07 gene in strain J14-26TR1 may 
also possibly form the basis of the strain's partial resistance to 
inhibition by tyrosine. If this increase in A7 mRNA is all 
translated into protein, then a specific concentration of tyrosine 
would not inhibit the enzyme as effectively as it would the unmutated 
strain expressing lower levels of chorismate mutase. 
This point, however, raises the question of why, if there is 
increased transcription of the A1307 gene in J14-261V9, is there not a 
corresponding increase in chorismate mutase activity ? The activity 
displayed by this strain, under conditions of no additional tyrosine, 
was almost half that displayed by strain J14-26TR1. There are several 
reasons for this 
First, perhaps not all the mRNA produced is available for 
translation into protein. 
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Secondly, if resistance to 
inhibition is caused by a mutation in the structural gene, the 
resulting conformational change may also affect the enzyme's activity. 
Thirdly, there may be other independent mutations in the structural 
gene which reduce the activity of the enzyme. 
Whichever reason is correct, these experiments provide strong 
evidence that the enzyme chorismate mutase is regulated at both the 
level of gene expression and post-trarislationally. 
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7. DISCUSSION 
The original aim of this project was to engineer overproduction 
of phenylalanine in Saecharonkvces cerevisiae. The results of chapter 
three indicated that it was possible to isolate mutant yeast strains 
secreting increased levels of phenylalanine by the relatively simple 
procedure of mutagenesis and selection for mutants resistant to the 
phenylalanine analogue, frthienylalanine. Mutant yeast strains 
secreting approximately 0.25 mg -' phenylalanine were obtained, 
phenylalanine secretion in wild-type strains was undetected, but the 
basic bioassay developed to detect such mutants could be adapted to 
select for ever-increasing levels of phenylalanine secretion. 
Repeated rounds of mutagenesis may result in a yeast strain secreting 
a relatively large amount of the amino acid but the genetic basis of 
the phenotype would be difficult to determine and the acquirement of 
additional, unselected and possibly deleterious, random mutations 
could not be prevented. These problems led to the decision to attempt 
to achieve phenylalanine overproduction by manipulating yeast in a 
much more controlled manner. 
By isolating and mutating specific genes coding for regulatory 
enzmes in the pathway, it was considered possible to direct the 
metabolic flux through to the phenylalanine branch, bypassing the 
controls that exist in wild-type cells. The results are summarised as 
follows 
The Saccharomyces cerevisiae AF37 gene coding for chorismate 
mutase, a key regulatory enzyme, was cloned by screening a wild-type 
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gene-bank for complementation of an aro7 auxotrophic mutant. A 
restriction map of the plasmid and cloned insert (pJFB1) was obtained 
and the size of the insert estimated to be 5.3 kb. Deletion analysis 
of pJFBl showed the complementing activity was located around a 
HithIII site at 12.7 on the plasmid map with full activity present in 
a subclone containing the 2.7 kb BglII - ClaI fragment. The location 
of the promoter was estimated to be around the ClaI site at 12.4 on 
the map. Transcriptional analysis revealed that pJFB1 produced a 1 kb 
transcript which is poly-adenylalated and enzyme assays showed an 
increase in chorismate mutase activity in the aro7 auxotrophic strain 
transformed with pJP131. 
The plasmid pJFB1 was mutated in vitro with O-methylhydroxylainine 
to obtain a yeast strain producing chorismate mutase that was 
resistant to the feedback-inhibition by tyrosine displayed by 
wild-type cells. The chorismate mutase activity from four mutant 
strains were analysed, two of which, J14-261V3 and J14-261V9, showed 
increased resistance to inhibition by tyrosine compared to the yeast 
strain transformed with the wild-type pJFB1 (J14-26TR1). 
No activation of chorismate mutase by tryptophan was observed but 
the presence of tryptophan did counteract inhibition by tyrosine. 
Phenylalanine did not appear to have any significant effect on 
chorismate rnutase activity. 
During the course of this enzyme analysis it was discovered that 
adthing tyrosine to the growth media also resulted in a decrease in 
chorismate mutase activity. This excess tyrosine was removed before 
assaying and therefore indicated that repression rather than 
inhibition was the cause of the decrease in enzyme activity. 
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The effect of tyrosine on transcription of the AF07 gene was 
subsequently analysed in more to detail to ascertain whether this 
I. repression" effect was the result of an actual decrease in the 
amount of AR07 transcript produced. A combination of Northern and 
slot-blot analysis revealed that the level of transcript decreased 
approximately ten-fold from 0 to 5 mM tyrosine, compared to total RNA 
levels. The plasmid copy number did not change throughout indicating 
that this decrease was due to an actual decrease in the transcription 
rate of the AR07 gene rather than a decrease in the number of genes 
transcribed. 
Two of the regulatory mutants isolated appeared to be resistant 
to this repression by tyrosine, increasing tyrosine in the growth 
medium having much less effect. on their chorismate mutase activity 
than in the wild-type transformant. A more thorough transcriptional 
analysis of one of these strains, J14-261V9, showed that the level of 
AR07 transcript did not decrease significantly as the concentration of 
tyrosine increased. Again the plasmid copy number was shown to be 
approximately constant over the range of tyrosine concentrations. It 
was, therefore, concluded that transcription of the AF7 gene in this 
strain was resistant to tyrosine repression. 
Although tyrosine-mediated repression of chorismate mutase has 
been well documented in E. coil (Camakaris & Pittard, 1983; Hudson & 
Davidson, 1984) it has not been reported in Saccharomyces cerevisiae. 
Another research group working with the AR07 gene reported that the 
gene was constitutively expressed, showing no difference in ATh07 mRNA 
levels between strains grown with and without 1 mM tyrosine and 
phenylalanine (Ball et ai.,1986). This failure to detect tyrosine 
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repression may have been due to several reasons. First, an external 
concentration of 1 mM tyrosine may not repress transcription 
sufficiently enough to be detected. Secondly, they were analysing 
samples of total RNA extracted from wild-type cells. The A107 
transcript appears to be expressed at very low levels so a slight 
change in the transcript level may have been difficult to detect. 
Repression by tyrosine indicates the existence of a repressor 
molecule which, in the presence of tyrosine, binds to the DNA 
preventing transcription. Positive control, however, is the more 
common form of regulation in eukaryotes (Lewin, 1983) indicating that 
tyrosine may possibly inhibit the binding of regulatory protein 
necessary for aro7 transcription. This situation, however, leads to 
the conclusion that in vitro mutagenesis of the AR07 gene has resulted 
in a DNA alteration enabling it to bind the protein in the presence of 
tyrosine. This requires a more complex alteration than a mutation 
preventing binding of a repressor molecule but the possibility cannot 
be disregarded. The isolation of other AR07 regulatory mutants, 
especially mutations causing constitutive expression, would help to 
determine which method of control is operating. 
There are very few reports of regulation of gene expression in 
any of the other genes for aromatic amino acid biosynthesis. The DAHP 
synthase isoenzymes are not repressed by any of the amino acids, 
either singly or in combination, nor is dehydroquinate dehydrat.ase 
(Doy & Cooper, 1966). Lingens et al. described an induction of 
chorismate mutase by tryptophan but this could not be confirmed by 
this work or others (Kradolfer et a]., 1977; Ball et a]., 1986). 
Prephenate dehydratase is, however, reported to be repressed by 
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phenylalanine while prephenate dehydrogenase is induced by 
phenylalanine but not repressed by tyrosine (Lingens et al., 1967). 
These effects are of the order of two to three-fold whereas feedback 
inhibition can be a hundred-fold effect. The latter has, therefore, 
always been cited as the main mode of control. The results of this 
work, however, indicate that repression may be more important in the 
regulation of aromatic amino acid biosynthesis than previously 
thought. 
Transcriptional control has been implicated in the derepression 
of tryptophan biosynthetic enzymes in response to tryptophan 
starvation (Miozzari et al., 1977). Derepression of these enzymes 
also occurred, however, in response to starvation for unrelated 
metabolites such as arginine and histithne and, therefore, it was 
concluded to be not a tryptophan-specific response but elicited by the 
general amino acid control system. This raises questions of whether 
the A197 gene is under general amino acid control and if the observed 
repression by excess tyrosine is associated with it ? 
This could be ascertained by comparing the chorismate mutase 
activity of wild-type yeast strains grown on complete medium to the 
same strain grown under phenylalanine/tyrosine limiting conditions. 
Analysis of the tryptophan biosynthetic pathway (Miozzari et al., 
1977) revealed that the enzymes were present at levels in excess of 
that required for normal growth. Changes in the tryptophan pool size 
were, therefore, not reflected in enzyme levels until tryptophan 
became growth limiting. If this is also the case in phenylalanine 
biosynthesis then creating phenylalanine/tyrosine limiting conditions 
may involve using bradyotrophic strains or phenylalanine/tyrosine 
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analozues which inhibit specific steps in the pathway. 
It would also be useful to check if there was a response in AR07 
expression to starvation for other amino acids known to be under 
general control. The same analysis could also be carried out using 
gcn mutant strains. The enzymes normally under general control are 
not derepressed in these mutant strains so any difference in 
chorismate activity between these strains and wild-type may be 
attributed to the effect of this cross-pathway control. 
Any indication of derepression mediated by the general control 
system could be investigated further by analysing directly the levels 
of the AR07 transcript produced by cells grown under the appropriate 
conditions. 
Even if the AR07 gene is under general amino acid control, the 
observed repression by tyrosine may not be directly associated with 
this control. The yeast cell's internal tyrosine pool concentration is 
apoximately 0.7 ITLM (Jones & Fink, 1982). The tyrosine concentrations 
which evoked this repression response may, therefore, be well above 
the normal physiological levels encountered by the cell. It may be 
that this repression is part of an emergency responseto extreme 
conditions. 
The mutant strain J14-261V9 appears to be resistant to both 
repression and feedback-inhibition by tyrosine, indicating that there 
are at least two separate mutations within the plasmid pJFB1, one in 
the upstream regulatory sequences and the other in the structural AR07 
gene. More information, however, is required before these two 
mutations can be separated and analysed independently. Once the 
transcription initiation site has been elucidated it may be possible 
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to isolate the mutated upstream controlling regions, link them to the 
wild-type AROT structural gene sequences and observe if the resulting 
construct still showed resistance to repression but produced a protein 
sensitive to feedback-inhibition. Alternatively, the existance of two 
separate mutations could also be proved by linking the mutated 
structural gene to wild-type upstream sequences and showing that 
there was inhibition without repression. 
Given that repression exists, it is not surprising that a double 
mutant has been isolated since mutant strains resistant only to 
feedback-inhibition by tyrosine would still be repressed and, 
therefore, difficult to select. Similarly, feedback-inhibition may be 
suppressing the phenotype of repression resistant mutants. This is 
assuming, however, that loss of feedback-inhibition results in an 
overproduction of tyrosine sufficient to repress transcription of the 
AF?07 gene and vice versa. 
The transcriptional analysis was carried out using the mutant 
yeast strain J14-261V9. The other mutant strains must, therefore, be 
further analysed to check that a) the enzyme activity results 
displayed by J14-261V6, indicating resistance to repression, are 
reflected in the AF07 transcript levels, and b) the apparent 
resistance to inhibition by tyrosine shown by J14-261V3 is not due to 
increased expression of the gene or an increase in the plasmid copy 
number. 
A relatively simple method of determining whether the 
feedback-inhibition resistant strains are producing an enzyme with an 
altered tyrosine binding site involves the use of tyrosine-linked 
agarose beads. By reacting cellular extracts of soluble protein with 
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the agarose beads and comparing bound and unbound fractions by 
polyacrylamide gel electrophoresis, the binding status of each enzyme 
may be determined. The chorismate mutase protein produced by a 
wild-type strain will be able to bind tyrosine and, therefore, bind to 
the tyrosine-linked agarose. If the mutant enzymes produced by strain 
J14-261V3 and J14-261V9 are unable to bind tyrosine they will not bind 
to the beads and, therefore, the protein will be present in the 
unbound fraction. 
Tryptophan-linked agarose could be used in a similar manner to 
detect if the tryptophan binding has been altered. Gel 
electrophoresis of soluble protein extracts would also reveal any 
possible differences in the electrophoretic mobility of the mutant 
enzymes due to conformational changes. 
Tryptophan may counteract inhibition by tyrosine in several ways: 
If tyrosine effects inhibition by binding to an allosteric site then 
tryptophan may prevent this by competitively binding to the same site. 
Alternatively tryptophan may bind to a separate allosteric site, 
changing the conformation of the enzyme in such a way that tyrosine 
can no longer bind. If tyrosine is a competitive inhibitor, tryptophan 
may counteract this by either of the two routes mentioned above. This 
is unlikely, however, since it is difficult to visualise how the 
binding of tryptophan may prevent tyrosine binding but preserve a 
fully functional active site. In the absence of specific enzyme 
kinetic parameters and structural information, however, this remains 
just speculation. 
Ball et al. (1986) report that (29M2, a gene required for growth 
123 
in hypertonic medium, maps to the A07 locus indicating that they are 
the same gene. A possible explanation for the osmotic sensitivity of 
aro7 mutants may be that depletion of an intermediate in the 
tyrosine/phenylalanine pathway leads to the absence or malfunction of 
a membrane component. Mutant yeast strains hypersensitive to 
naladixic acid map to the same complementation group as aro7 mutants 
(J.A. Prendergast, personal communication) and Meade & Manney (1983) 
showed that at least a quarter of phenethylalcohol hypersensitive 
mutants are amino acid auxotrophs. Growth inhibition by the latter 
compound is generally believed to be mediated by its effect on the 
cell membrane, thus the aromatic amino acid pathway might be of 
particular importance for its normal function. This may explain why 
the phenylalanine overproducing mutants, discussed in chapter three, 
secreted many other amino acids. It would be interesting to test these 
and other known mutants in the aromatic amino acid pathway for similar 
osmotic and hypersensitivity effects. 
Although strain J14-261V9 is insensitive to feedback-inhibition 
and repression by tyrosine, it only secreted 0.1 mg ml -1 
phenylalanine, indicating that deregulation of chorismate mutase alone 
may not alter the flux of the pathway sufficiently to achieve 
significant overproduction of phenylalanine. To obtain overproducing 
strains adequate for commercial purposes, which require 20-30 g 1-1 
it may , therefore, be necessary to deregulate other key enzymes in 
the pathway. These would include AR03, AR04 and P1i42. The AR03 gene 
has been cloned by complementation of an aro3 mutation with a 
wild-type gene bank (Teshiba et al., 1986) so it should be possible 
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to isolate the other genes in a similar manner and obtain the required 
mutant by in vitro mutagenesis. To maximise phenylalanine production, 
it may also be necessary to restrict the flow of metabolites into the 
tryptophan and tyrosine pathway by using bradytrophic strains. The 
deregulation of the phenylalanine pathway through multiple 
feedback-resistant mutations may, however, result in the flux of 
intermediates to phenylalanine becoming limiting. 
Miozarri et al. (1978) demonstrated, by both biochemical and 
genetic analysis, that most enzymes of the tryptophan pathway are 
present in excess of the levels necessary for wild-type cell growth. 
In a feedback-resistant mutant, however, onactivatjoranthranilate 
phospho-ribosyl transferase (TRP4), did limit the maximum capacity of 
the pathway. Kradolfer et al. (1977) reported that mutants containing 
high chorisrnate mutase activity have a reduced chorismate pool, thus a 
similar situation may arise in a multiple feedback-resistant, 
phenylalanine overproducing cell. 
If the limitation is due to a low concentration of an enzyme, 
this may be increased by two methods. The gene dosage may be 
increased by introducing the specific gene on a high copy number 
plasmid, or, if a detailed restriction map of the gene is available, 
the natural promoter may be removed and replaced with a stronger - 
constitutive one such as the phosphoglycerate kinase (PK) promoter. 
Thus, gene expression is increased either by increasing the gene copy 
or elevating the transcription of mRNA. 
The results of this project also suggest that overproduction of 
phenyalanine could affect the production of the pathway at the level 
of transcription, thus over-riding the former method of increasing 
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gene expression. This may necessitate the use of either specific 
amino acid repression resistant mutants or general control mutants 
(gcdl, gcd2) which are no longer subject to this repression control 
and have high, constitutive levels of amino acid biosynthetic enzymes 
(Wolfner et al., 1975; Miozarri et al., 1978; Myers et al., 1986). 
No effort to achieve high yields of an amino acid from 
Saccharomyces cerevisiae can neglect the effect of carbon metabolism 
on biosynthesis. The carbon precursors of the aromatic amino acids 
are erythrose-4-phosphate and phosphoenolpyruvate, intermediates of 
the pentose phosphate pathway and glycolysis respectively. 
A pyruvate kinase deficient mutant may also be used to divert 
PEP from the glycolytic pathway into the phenylalanine pathway. 
Mutants in pyruvate kinase (pyk) cannot grow on glucose because 
glycolysis is blocked and their growth on non-fermentable carbon 
sources is inhibited by glucose due to the build up of toxic levels of 
glycolytic intermediates (Maitri & Lobo, 1977). Temperature-sensitive 
alleles of pyruvate kinase (cdc19) could be used to increase cellular 
PEP concentrations so that pyruvate kinase activity can be adjusted to 
allow sufficient glycolysis for energy generation, and to prevent the 
accumulation of toxic levels of PEP. An investigation of the effect of 
the above mutation on phenylalanine biosynthesis would, 
therefore, be extemely useful in maximising phenylalanine production. 
The simplest method of amalgamating these necessary mutations 
would be to combine the genes for phenylalanine biosynthesis, using 
feedback-insensitive and other deregulated mutants where necessary, on 
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the one high copy plasmid. This could then be transformed into a host 
yeast strain with the appropriate genetic background. This has 
already been achieved with the tryptophan biosynthetic genes (Prasad 
et al., 1987). This may result, however, in problems with plasmid 
stability, an important point if the strain is to be used in 
industrial-scale fermentation procedures. Prasad et al. (1987) 
reported that presence of tryptophan in the media, either added 
externally or excreted from the cells, resulted in the loss of the 
plasmid from 90% of the cells in 24 h (approx. ten doublings). This 
indicates that the phenylalanine produced by the transformed cells 
would result in the loss of the plasmid responsible from the cell. 
Integrating genetically engineered constructs into one site in 
the yest genome is the common solution to this problem, but this 
generally results in the loss of advantages gained by placing them on 
a high copy number vector. It should be possible, however, to 
introduce multiple copies of a given construct into a strain by using 
integrating vectors. Tandem copies of a gene can be lost through 
intrachromosomal recombination and may, therefore, prove to be just as 
unstable as plasmids. Integrating vectors often carry several segments 
of yeast DNA and are, therefore, capable of integrating at several 
sites in the yeast genome. A given transformant will probably contain 
only one copy of the construction, but the integration events from 
several different transformations can be combined into a single strain 
through successive rounds of mating and sporulation. This should 
eventually lead to a stable multicopy integrant. Ultimately, it may 
be feasible to construct an artificial chromosome (Murray & Szost.ak, 
1983) incorporating all of the biosynthetic genes, in single or 
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multiple copies as required. 
The results of this project and the above discussion indicate 
that the genetic manipulation of yeast to obtain overproduction of 
phenylalanine at commercially useful levels is a complex procedure. 
Many different aspects of gene expression, enzyme regulation and cell 
physiology have to be considered. The information obtained from 
studying these different areas, however, should lead not only to 
commercial success but also to a fuller understanding of the 
regulation of aromatic amino acid biosynthesis in Saccharoinyces 
cerevi Si ae. 
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